Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	DNA-binding transcription activator activity, RNA polymerase II-specific	HNF1A BACH1 GATA2 ETV6 POU1F1 ONECUT1 STAT6 TBX19 TFCP2L1 NFIA HSF1 PRDM16 NPAS4 FOXC1 ZNF574 ZNF292	1.25e-06	560	135	16	GO:0001228
GeneOntologyMolecularFunction	DNA-binding transcription activator activity	HNF1A BACH1 GATA2 ETV6 POU1F1 ONECUT1 STAT6 TBX19 TFCP2L1 NFIA HSF1 PRDM16 NPAS4 FOXC1 ZNF574 ZNF292	1.44e-06	566	135	16	GO:0001216
GeneOntologyMolecularFunction	transcription factor binding	ZNF703 FLNA HNF1A GATA2 POU1F1 LYAR IFI16 STAT6 UBN1 NFIA KMT2A MYOCD PKN1 HSF1 PRDM16 FOXC1	5.03e-05	753	135	16	GO:0008134
GeneOntologyMolecularFunction	MAP-kinase scaffold activity	MAPK8IP1 SH3RF1 KSR2	8.23e-05	13	135	3	GO:0005078
GeneOntologyMolecularFunction	chromatin binding	HNF1A GATA2 POU1F1 MLLT10 ONECUT1 TRIM33 TOX4 NFIA MORF4L1 AUTS2 KMT2A SMARCC2 PKN1 HSF1 FOXC1	1.45e-04	739	135	15	GO:0003682
GeneOntologyMolecularFunction	histone H3 methyltransferase activity	KMT2B KMT2E KMT2A PRDM16	2.20e-04	44	135	4	GO:0140938
GeneOntologyMolecularFunction	DNA-binding transcription factor binding	ZNF703 FLNA GATA2 POU1F1 LYAR NFIA KMT2A MYOCD PKN1 HSF1 PRDM16 FOXC1	5.99e-04	582	135	12	GO:0140297
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	HNF1A MKRN2 BACH1 GATA2 ETV6 POU1F1 GRIN1 MLLT10 IFI16 ONECUT1 STAT6 TBX19 MET TFCP2L1 NFIA AUTS2 KMT2A MYOCD ATM CAMTA1 HSF1 PRDM16 NPAS4 FOXC1 ZNF574 ZNF292	8.73e-07	1390	134	26	GO:0045944
GeneOntologyBiologicalProcess	hemopoiesis	FLNA SH3RF1 GATA2 ETV6 POU1F1 TNRC6C LYAR KMT2E IFI16 ONECUT1 STAT6 RASGRP1 ARHGEF7 CD27 NBEAL2 FLCN KMT2A SMARCC2 CD74 ATM HSF1 PRDM16 FOXC1	3.79e-06	1223	134	23	GO:0030097
GeneOntologyBiologicalProcess	negative regulation of transcription by RNA polymerase II	HNF1A BACH1 GATA2 ETV3 ETV6 POU1F1 IRX1 LYAR IFI16 HEXIM2 STAT6 TRIM33 MET ZNF469 TFCP2L1 FLCN SMARCC2 MYOCD HSF1 PRDM16 FOXC1	4.31e-06	1053	134	21	GO:0000122
GeneOntologyBiologicalProcess	chromatin remodeling	FAM47A UBR2 TTF2 HNF1A KMT2B KMT2E IFI16 UBN1 MORF4L1 RAD54B KMT2A SMARCC2 MYOCD PKN1 ATM PRDM16	2.57e-05	741	134	16	GO:0006338
GeneOntologyBiologicalProcess	determination of adult lifespan	POU1F1 TFCP2L1 RAD54B ATM BBC3	2.63e-05	54	134	5	GO:0008340
GeneOntologyBiologicalProcess	negative regulation of DNA-templated transcription	ZNF703 FLNA HNF1A BACH1 GATA2 ETV3 ETV6 POU1F1 IRX1 LYAR IFI16 HEXIM2 STAT6 TRIM33 MET ZNF469 TFCP2L1 FLCN SMARCC2 MYOCD HSF1 PRDM16 FOXC1	3.30e-05	1399	134	23	GO:0045892
GeneOntologyBiologicalProcess	negative regulation of RNA biosynthetic process	ZNF703 FLNA HNF1A BACH1 GATA2 ETV3 ETV6 POU1F1 IRX1 LYAR IFI16 HEXIM2 STAT6 TRIM33 MET ZNF469 TFCP2L1 FLCN SMARCC2 MYOCD HSF1 PRDM16 FOXC1	3.86e-05	1413	134	23	GO:1902679
GeneOntologyBiologicalProcess	positive regulation of cell migration	ZNF703 FLNA ELP5 GATA2 SEMA5A GRIN1 BCAR1 ONECUT1 MET COL18A1 ARHGEF7 IQSEC1 CD74 MYOCD ATM	4.41e-05	691	134	15	GO:0030335
GeneOntologyBiologicalProcess	gland development	ZNF703 HNF1A ACO2 GATA2 POU1F1 ONECUT1 STAT6 TBX19 MET TFCP2L1 SULF1 ATM FOXC1	7.21e-05	558	134	13	GO:0048732
GeneOntologyBiologicalProcess	positive regulation of cell motility	ZNF703 FLNA ELP5 GATA2 SEMA5A GRIN1 BCAR1 ONECUT1 MET COL18A1 ARHGEF7 IQSEC1 CD74 MYOCD ATM	7.57e-05	725	134	15	GO:2000147
GeneOntologyBiologicalProcess	positive regulation of intracellular signal transduction	MAPK8IP1 FLNA HNF1A SH3RF1 L1CAM KSR2 SEMA5A MET RASGRP1 TRAF4 CASTOR1 CD27 TRIM62 AUTS2 FLCN CD74 PLA2G6 ATM CAMTA1 KLK2 BBC3	9.65e-05	1299	134	21	GO:1902533
GeneOntologyBiologicalProcess	positive regulation of locomotion	ZNF703 FLNA ELP5 GATA2 SEMA5A GRIN1 BCAR1 ONECUT1 MET COL18A1 ARHGEF7 IQSEC1 CD74 MYOCD ATM	9.79e-05	742	134	15	GO:0040017
GeneOntologyBiologicalProcess	positive regulation of cellular component organization	FLNA TRABD2B L1CAM WASF3 GATA2 SEMA5A GRIN1 LYAR ZNF804A TRAK1 MET CNOT6L PTPRD ARHGEF7 IQSEC1 AUTS2 PLA2G6 ATM HSF1 BBC3 ARAP1	1.94e-04	1366	134	21	GO:0051130
GeneOntologyBiologicalProcess	small GTPase-mediated signal transduction	DENND4A LZTR1 CDC42BPA KSR2 MET RASGRP1 ARHGEF7 IQSEC1 AUTS2 FLCN KLK2 ARAP1	2.07e-04	538	134	12	GO:0007264
GeneOntologyBiologicalProcess	chromatin organization	FAM47A UBR2 TTF2 HNF1A KMT2B KMT2E IFI16 UBN1 MORF4L1 RAD54B KMT2A SMARCC2 MYOCD PKN1 ATM PRDM16	2.36e-04	896	134	16	GO:0006325
GeneOntologyBiologicalProcess	cell morphogenesis	HSPG2 FLNA MAP1A STXBP5 L1CAM WASF3 SEMA5A GRIN1 TRAK1 MET COL18A1 TFCP2L1 PTPRD NFIA ARHGEF7 NBEAL2 AUTS2 KIF5C ARAP1	2.62e-04	1194	134	19	GO:0000902
GeneOntologyBiologicalProcess	regulation of transforming growth factor beta receptor signaling pathway	ZNF703 ONECUT1 TRIM33 FLCN MYOCD LTBP1 PRDM16	2.63e-04	192	134	7	GO:0017015
GeneOntologyBiologicalProcess	mononuclear cell differentiation	SH3RF1 GATA2 POU1F1 IFI16 ONECUT1 STAT6 RASGRP1 CD27 KMT2A SMARCC2 CD74 ATM HSF1	2.78e-04	640	134	13	GO:1903131
GeneOntologyBiologicalProcess	regulation of cellular response to transforming growth factor beta stimulus	ZNF703 ONECUT1 TRIM33 FLCN MYOCD LTBP1 PRDM16	2.89e-04	195	134	7	GO:1903844
GeneOntologyCellularComponent	axonal growth cone	MAPK8IP1 FLNA L1CAM TRAK1 KIF5C	1.15e-05	45	138	5	GO:0044295
GeneOntologyCellularComponent	growth cone	MAPK8IP1 FLNA L1CAM GRIN1 ZNF804A TRAK1 ARHGEF7 AUTS2 KIF5C	3.72e-05	245	138	9	GO:0030426
GeneOntologyCellularComponent	site of polarized growth	MAPK8IP1 FLNA L1CAM GRIN1 ZNF804A TRAK1 ARHGEF7 AUTS2 KIF5C	4.77e-05	253	138	9	GO:0030427
GeneOntologyCellularComponent	chromatin	FAM47A UBR2 HNF1A BACH1 TLX3 ETV3 ETV6 POU1F1 IRX1 KMT2E ONECUT1 STAT6 TBX19 TRIM33 TFCP2L1 TOX4 NFIA MORF4L1 SMARCC2 MYOCD HSF1 NPAS4 FOXC1	1.02e-04	1480	138	23	GO:0000785
GeneOntologyCellularComponent	dendritic microtubule	MAP1A ZNF804A	2.57e-04	4	138	2	GO:1901588
GeneOntologyCellularComponent	distal axon	MAPK8IP1 FLNA MAP1A L1CAM GRIN1 ZNF804A TRAK1 ARHGEF7 AUTS2 KIF5C	6.36e-04	435	138	10	GO:0150034
GeneOntologyCellularComponent	dendritic branch	MAP1A GRIN1	8.89e-04	7	138	2	GO:0044307
Domain	-	UBR2 KMT2B SH3RF1 CBLL2 MKRN2 MLLT10 KMT2E TRIM33 TRAF4 ZNRF3 TRIM62 KMT2A DTX2	2.13e-05	449	134	13	3.30.40.10
Domain	Znf_RING/FYVE/PHD	UBR2 KMT2B SH3RF1 CBLL2 MKRN2 MLLT10 KMT2E TRIM33 TRAF4 ZNRF3 TRIM62 KMT2A DTX2	2.68e-05	459	134	13	IPR013083
Domain	ZF_RING_1	UBR2 SH3RF1 CBLL2 MKRN2 TRIM33 TRAF4 ZNRF3 TRIM62 UNKL DTX2	4.81e-05	291	134	10	PS00518
Domain	MeTrfase_trithorax	KMT2B KMT2A	5.11e-05	2	134	2	IPR016569
Domain	ZF_RING_2	UBR2 SH3RF1 CBLL2 MKRN2 TRIM33 TRAF4 ZNRF3 TRIM62 UNKL DTX2	5.87e-05	298	134	10	PS50089
Domain	RING	UBR2 SH3RF1 CBLL2 MKRN2 TRIM33 TRAF4 ZNRF3 TRIM62 UNKL DTX2	7.13e-05	305	134	10	SM00184
Domain	Znf_RING	UBR2 SH3RF1 CBLL2 MKRN2 TRIM33 TRAF4 ZNRF3 TRIM62 UNKL DTX2	1.23e-04	326	134	10	IPR001841
Domain	PHD	KMT2B MLLT10 KMT2E TRIM33 KMT2A	2.04e-04	75	134	5	PF00628
Domain	Znf_PHD-finger	KMT2B MLLT10 KMT2E TRIM33 KMT2A	2.60e-04	79	134	5	IPR019787
Domain	SET	KMT2B KMT2E KMT2A PRDM16	3.27e-04	46	134	4	SM00317
Domain	SET_dom	KMT2B KMT2E KMT2A PRDM16	4.52e-04	50	134	4	IPR001214
Domain	SET	KMT2B KMT2E KMT2A PRDM16	4.52e-04	50	134	4	PS50280
Domain	PHD	KMT2B MLLT10 KMT2E TRIM33 KMT2A	4.52e-04	89	134	5	SM00249
Domain	Znf_PHD	KMT2B MLLT10 KMT2E TRIM33 KMT2A	5.01e-04	91	134	5	IPR001965
Domain	Znf_C2H2_jaz	GPATCH8 ZNF804A ZNF804B	5.03e-04	22	134	3	IPR022755
Domain	zf-C2H2_jaz	GPATCH8 ZNF804A ZNF804B	5.03e-04	22	134	3	PF12171
Domain	EPHD	KMT2B MLLT10 KMT2A	5.03e-04	22	134	3	PS51805
Domain	FYrich_C	KMT2B KMT2A	5.04e-04	5	134	2	IPR003889
Domain	FYrich_N	KMT2B KMT2A	5.04e-04	5	134	2	IPR003888
Domain	FYRC	KMT2B KMT2A	5.04e-04	5	134	2	SM00542
Domain	FYRN	KMT2B KMT2A	5.04e-04	5	134	2	SM00541
Domain	FYRN	KMT2B KMT2A	5.04e-04	5	134	2	PF05964
Domain	FYRC	KMT2B KMT2A	5.04e-04	5	134	2	PF05965
Domain	FYRC	KMT2B KMT2A	5.04e-04	5	134	2	PS51543
Domain	FYRN	KMT2B KMT2A	5.04e-04	5	134	2	PS51542
Domain	ZF_PHD_2	KMT2B MLLT10 KMT2E TRIM33 KMT2A	6.10e-04	95	134	5	PS50016
Domain	ZF_PHD_1	KMT2B MLLT10 KMT2E TRIM33 KMT2A	6.39e-04	96	134	5	PS01359
Domain	Haem_d1	STXBP5 KMT2A	7.52e-04	6	134	2	IPR011048
Domain	-	HNF1A POU1F1 ONECUT1	9.31e-04	27	134	3	1.10.260.40
Domain	Lambda_DNA-bd_dom	HNF1A POU1F1 ONECUT1	1.15e-03	29	134	3	IPR010982
Domain	Znf_RING_CS	SH3RF1 CBLL2 MKRN2 TRIM33 TRAF4 TRIM62	1.15e-03	163	134	6	IPR017907
Domain	Znf_C3HC4_RING-type	SH3RF1 MKRN2 TRAF4 ZNRF3 TRIM62 DTX2	1.52e-03	172	134	6	IPR018957
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	HSPG2 FLNA FAM193B LZTR1 CDC42BPA KMT2B SH3RF1 L1CAM KSR2 GATA2 PFAS TNRC6C MLLT10 IFNLR1 TRAK1 TRAF4 C2CD3 UBN1 ZNRF3 NBEAL2 NAV1 FLCN UNKL PLA2G6 PKN1 DTX2 PRDM16 ARAP1	7.38e-15	1105	141	28	35748872
Pubmed	Human transcription factor protein interaction networks.	ATP5PB ZNF703 HSPG2 HNF1A CDC42BPA KMT2B RTCB ACO2 TLX3 GATA2 ETV3 ETV6 TNRC6C GPATCH8 MLLT10 HEXIM2 TRIM33 UBN1 NFIA MORF4L1 AUTS2 KMT2A SMARCC2 PRDM16 FOXC1	6.62e-10	1429	141	25	35140242
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	HNF1A LZTR1 SH3RF1 MKRN2 BACH1 GATA2 ETV6 MLLT10 ONECUT1 MET TFCP2L1 TOX4 NFIA TRIM62 KMT2A PRDM16 NPAS4 ZNF292	7.07e-10	709	141	18	22988430
Pubmed	A census of human transcription factors: function, expression and evolution.	HNF1A BACH1 TLX3 GATA2 ETV3 ETV6 POU1F1 IRX1 ONECUT1 STAT6 TBX19 TFCP2L1 TOX4 NFIA KMT2A UNKL CAMTA1 HSF1 FOXC1	5.46e-09	908	141	19	19274049
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	ATXN2L FLNA KMT2B SAMD4B BACH1 SEMA5A GPATCH8 IFI16 HEXIM2 UBN1 NFIA IQSEC1 KMT2A SMARCC2 PKN1 ATM HSF1	1.84e-08	774	141	17	15302935
Pubmed	FOXC1 transcriptional regulatory activity is impaired by PBX1 in a filamin A-mediated manner.	FLNA NFIA FOXC1	2.60e-07	4	141	3	15684392
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	UBR2 CDC42BPA SAMD4B WASF3 KSR2 ZNF362 TNRC6C BCAR1 HEXIM2 COL18A1 NFIA FBXO42 AUTS2 NAV1 PLA2G6 PKN1 KIF5C CAMTA1 RECK ARAP1 FAM149A	6.51e-07	1489	141	21	28611215
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	HNF1A LZTR1 MKRN2 BACH1 GATA2 ETV3 ETV6 MLLT10 ONECUT1 TBX19 TFCP2L1 TOX4 HSF1 PRDM16 ZNF292	1.11e-06	808	141	15	20412781
Pubmed	A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration.	ATXN2L HSPG2 FAM193B KMT2B ELP5 ACO2 GPATCH8 ZNF804A TOX4 ZNRF3 SMARCC2 LTBP1 DTX2	1.29e-06	608	141	13	16713569
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	ATXN2L DENND4A CDC42BPA SH3RF1 RTCB SAMD4B BACH1 BCAR1 TRAK1 C2CD3 MAST4 IQSEC1 NAV1 KMT2A KIF5C	2.42e-06	861	141	15	36931259
Pubmed	Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases.	KMT2B KMT2E KMT2A	3.60e-06	8	141	3	23130995
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	WASF3 FNDC3A TNRC6C ZNRF3 AUTS2 CAMTA1 PRDM16 ARAP1	4.10e-06	225	141	8	12168954
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	KMT2B ZNF362 GPATCH8 LYAR UBN1 NFIA MORF4L1 RAD54B KMT2A SMARCC2 FOXC1 ZNF292	7.53e-06	608	141	12	36089195
Pubmed	Tbx3 controls the fate of hepatic progenitor cells in liver development by suppressing p19ARF expression.	HNF1A ONECUT1 TBX19 MET	9.67e-06	33	141	4	18356246
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	MAP1A MLLT10 BCAR1 KMT2E ZNF804A ZNF469 UBN1 ATM CAMTA1 ARAP1	1.10e-05	430	141	10	35044719
Pubmed	Tbx19, a tissue-selective regulator of POMC gene expression.	GATA2 POU1F1 TBX19	1.40e-05	12	141	3	11447259
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	TTF2 HNF1A DENND4A LZTR1 BACH1 TLX3 GATA2 MLLT10 STAT6 TBX19 TFCP2L1 CNOT6L MYOCD ZNF292	1.42e-05	877	141	14	20211142
Pubmed	Complementary quantitative proteomics reveals that transcription factor AP-4 mediates E-box-dependent complex formation for transcriptional repression of HDM2.	TTF2 TFCP2L1 NFIA SMARCC2 PRDM16	1.59e-05	77	141	5	19505873
Pubmed	The structure of the human betaII-tryptase tetramer: fo(u)r better or worse.	TPSAB1 TPSB2	1.63e-05	2	141	2	10500112
Pubmed	Salivary Secretory Carcinoma With a Novel ETV6-MET Fusion: Expanding the Molecular Spectrum of a Recently Described Entity.	ETV6 MET	1.63e-05	2	141	2	29683815
Pubmed	A modifier gene alleviates hypothyroidism-induced hearing impairment in Pou1f1dw dwarf mice.	MAP1A POU1F1	1.63e-05	2	141	2	21840860
Pubmed	POSH participates in epileptogenesis by increasing the surface expression of the NMDA receptor: a promising therapeutic target for epilepsy.	SH3RF1 GRIN1	1.63e-05	2	141	2	29057721
Pubmed	Characterization of two highly polymorphic human tryptase loci and comparison with a newly discovered monkey tryptase ortholog.	TPSAB1 TPSB2	1.63e-05	2	141	2	10898108
Pubmed	Identification of mixed lineage leukemia 1(MLL1) protein as a coactivator of heat shock factor 1(HSF1) protein in response to heat shock protein 90 (HSP90) inhibition.	KMT2A HSF1	1.63e-05	2	141	2	24831003
Pubmed	Serine 249 phosphorylation by ATM protein kinase regulates hepatocyte nuclear factor-1α transactivation.	HNF1A ATM	1.63e-05	2	141	2	24821553
Pubmed	Molecular and fluorescence in situ hybridization analysis of a 10;11 rearrangement in a case of infant acute monocytic leukemia.	MLLT10 KMT2A	1.63e-05	2	141	2	12127405
Pubmed	Human beta-tryptase is a ring-like tetramer with active sites facing a central pore.	TPSAB1 TPSB2	1.63e-05	2	141	2	9521329
Pubmed	Human tryptases alpha and beta/II are functionally distinct due, in part, to a single amino acid difference in one of the surface loops that forms the substrate-binding cleft.	TPSAB1 TPSB2	1.63e-05	2	141	2	10391906
Pubmed	KMT2A and KMT2B Mediate Memory Function by Affecting Distinct Genomic Regions.	KMT2B KMT2A	1.63e-05	2	141	2	28723559
Pubmed	Reciprocal regulation of forkhead box C1 and L1 cell adhesion molecule contributes to triple-negative breast cancer progression.	L1CAM FOXC1	1.63e-05	2	141	2	38183514
Pubmed	Characterization of a tryptase mRNA expressed in the human basophil cell line KU812.	TPSAB1 TPSB2	1.63e-05	2	141	2	8434231
Pubmed	Direct interaction of the molecular scaffolds POSH and JIP is required for apoptotic activation of JNKs.	MAPK8IP1 SH3RF1	1.63e-05	2	141	2	16571722
Pubmed	Cloning and characterization of a second complementary DNA for human tryptase.	TPSAB1 TPSB2	1.63e-05	2	141	2	2203827
Pubmed	Consequences of Stat6 deletion on Sis/PDGF- and IL-4-induced proliferation and transcriptional activation in murine fibroblasts.	STAT6 KIF5C	1.63e-05	2	141	2	10602484
Pubmed	Deletion of the basement membrane heparan sulfate proteoglycan type XVIII collagen causes hypertriglyceridemia in mice and humans.	HSPG2 COL18A1	1.63e-05	2	141	2	21085708
Pubmed	Heparan sulfate chains of perlecan are indispensable in the lens capsule but not in the kidney.	HSPG2 COL18A1	1.63e-05	2	141	2	12514129
Pubmed	Hepatocyte NF-1 and STAT6 cooperate with additional DNA-binding factors to activate transcription of the human polymeric Ig receptor gene in response to IL-4.	HNF1A STAT6	1.63e-05	2	141	2	12794133
Pubmed	Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family.	TPSAB1 TPSB2	1.63e-05	2	141	2	2187193
Pubmed	Kaempferol induces apoptosis in human HCT116 colon cancer cells via the Ataxia-Telangiectasia Mutated-p53 pathway with the involvement of p53 Upregulated Modulator of Apoptosis.	ATM BBC3	1.63e-05	2	141	2	19028473
Pubmed	Structural requirements and mechanism for heparin-dependent activation and tetramerization of human betaI- and betaII-tryptase.	TPSAB1 TPSB2	1.63e-05	2	141	2	15567416
Pubmed	The human mast cell tryptase tetramer: a fascinating riddle solved by structure.	TPSAB1 TPSB2	1.63e-05	2	141	2	10708850
Pubmed	Tryptase haplotype in mastocytosis: relationship to disease variant and diagnostic utility of total tryptase levels.	TPSAB1 TPSB2	1.63e-05	2	141	2	17449330
Pubmed	Dysregulation of the DNA Damage Response and KMT2A Rearrangement in Fetal Liver Hematopoietic Cells.	KMT2A ATM	1.63e-05	2	141	2	26657054
Pubmed	Impact of naturally forming human α/β-tryptase heterotetramers in the pathogenesis of hereditary α-tryptasemia.	TPSAB1 TPSB2	1.63e-05	2	141	2	31337736
Pubmed	Nuclear factor I-A represses expression of the cell adhesion molecule L1.	L1CAM NFIA	1.63e-05	2	141	2	20003413
Pubmed	Tryptase activates calcium-independent phospholipase A2 and releases PGE2 in airway epithelial cells.	TPSAB1 PLA2G6	1.63e-05	2	141	2	18790994
Pubmed	PDE2A Is Indispensable for Mouse Liver Development and Hematopoiesis.	HNF1A ONECUT1 MET	2.30e-05	14	141	3	32326334
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	FAM193B DENND4A MAP1A PFAS TRAK1 MAST4 FBXO42	2.45e-05	209	141	7	36779422
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	ATXN2L ZNF703 SH3RF1 MAP1A PFAS BCAR1 TRIM33 UBN1 FBXO42 NAV1 ZNF574	2.98e-05	588	141	11	38580884
Pubmed	The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery.	ATXN2L FLNA TMEM201 QPCTL L1CAM FNDC3A ZNF362 GPATCH8 KMT2E IFI16 ONECUT1 MORF4L1 IQSEC1 AUTS2 SMARCC2 ZNF574	3.18e-05	1203	141	16	29180619
Pubmed	CEBPA-Associated Familial Acute Myeloid Leukemia (AML)	GATA2 ETV6 MLLT10	4.25e-05	17	141	3	20963938
Pubmed	ETV6 Thrombocytopenia and Predisposition to Leukemia	GATA2 ETV6 MLLT10	4.25e-05	17	141	3	33226740
Pubmed	RUNX1 Familial Platelet Disorder with Associated Myeloid Malignancies	GATA2 ETV6 MLLT10	4.25e-05	17	141	3	33661592
Pubmed	TDP-43 enhances translation of specific mRNAs linked to neurodegenerative disease.	DENND4A CAMTA1	4.88e-05	3	141	2	30357366
Pubmed	ETV3 and ETV6 enable monocyte differentiation into dendritic cells by repressing macrophage fate commitment.	ETV3 ETV6	4.88e-05	3	141	2	36543959
Pubmed	Targeting the kinase activities of ATR and ATM exhibits antitumoral activity in mouse models of MLL-rearranged AML.	KMT2A ATM	4.88e-05	3	141	2	27625305
Pubmed	Memory type 2 helper T cells induce long-lasting antitumor immunity by activating natural killer cells.	STAT6 KMT2A	4.88e-05	3	141	2	21646476
Pubmed	The mechanism of Ca2+ -dependent regulation of kinesin-mediated mitochondrial motility.	TRAK1 KIF5C	4.88e-05	3	141	2	19135897
Pubmed	Iterative Single-Cell Analyses Define the Transcriptome of the First Functional Hematopoietic Stem Cells.	GATA2 CD27	4.88e-05	3	141	2	32402290
Pubmed	Characterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3.	TPSAB1 TPSB2	4.88e-05	3	141	2	9920877
Pubmed	Analysis of the relationships between ATM and the Rad54 paralogs involved in homologous recombination repair.	RAD54B ATM	4.88e-05	3	141	2	19061978
Pubmed	A vHNF1/TCF2-HNF6 cascade regulates the transcription factor network that controls generation of pancreatic precursor cells.	HNF1A ONECUT1	4.88e-05	3	141	2	16380477
Pubmed	Hepatocyte growth factor receptor c-MET is associated with FAS and when activated enhances drug-induced apoptosis in pediatric B acute lymphoblastic leukemia with TEL-AML1 translocation.	ETV6 MET	4.88e-05	3	141	2	17673463
Pubmed	POSH regulates assembly of the NMDAR/PSD-95/Shank complex and synaptic function.	SH3RF1 GRIN1	4.88e-05	3	141	2	35385725
Pubmed	Pit-1 and GATA-2 interact and functionally cooperate to activate the thyrotropin beta-subunit promoter.	GATA2 POU1F1	4.88e-05	3	141	2	9305891
Pubmed	ATM and MET kinases are synthetic lethal with nongenotoxic activation of p53.	MET ATM	4.88e-05	3	141	2	22660439
Pubmed	A MET-PTPRK kinase-phosphatase rheostat controls ZNRF3 and Wnt signaling.	MET ZNRF3	4.88e-05	3	141	2	34590584
Pubmed	The POSH/JIP-1 scaffold network regulates TCR-mediated JNK1 signals and effector function in CD8(+) T cells.	MAPK8IP1 SH3RF1	4.88e-05	3	141	2	23963642
Pubmed	Domains of Pit-1 required for transcriptional synergy with GATA-2 on the TSH beta gene.	GATA2 POU1F1	4.88e-05	3	141	2	12385825
Pubmed	The clinical variability of the MECP2 duplication syndrome: description of two families with duplications excluding L1CAM and FLNA.	FLNA L1CAM	4.88e-05	3	141	2	19018795
Pubmed	Inhibition of suppressive T cell factor 1 (TCF-1) isoforms in naive CD4+ T cells is mediated by IL-4/STAT6 signaling.	HNF1A STAT6	4.88e-05	3	141	2	20980261
Pubmed	Control of pancreas and liver gene expression by HNF transcription factors.	HNF1A ONECUT1	4.88e-05	3	141	2	14988562
Pubmed	Distinct pathways of genomic progression to benign and malignant tumors of the liver.	HNF1A MET	4.88e-05	3	141	2	17785413
Pubmed	Human subjects are protected from mast cell tryptase deficiency despite frequent inheritance of loss-of-function mutations.	TPSAB1 TPSB2	4.88e-05	3	141	2	19748655
Pubmed	Pattern of genes influenced by conditional expression of the transcription factors HNF6, HNF4alpha and HNF1beta in a pancreatic beta-cell line.	HNF1A ONECUT1	4.88e-05	3	141	2	15520459
Pubmed	A higher-order configuration of the heterodimeric DOT1L-AF10 coiled-coil domains potentiates their leukemogenenic activity.	MLLT10 KMT2A	4.88e-05	3	141	2	31527241
Pubmed	A study of associations between CUBN, HNF1A, and LIPC gene polymorphisms and coronary artery disease.	HNF1A CUBN	4.88e-05	3	141	2	33004870
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	ELP5 KMT2E STAT6 IQSEC1 UNKL HSF1 ZNF292	4.89e-05	233	141	7	37704626
Pubmed	DDX41-Associated Familial Myelodysplastic Syndrome and Acute Myeloid Leukemia	GATA2 ETV6 MLLT10	5.09e-05	18	141	3	34723452
Pubmed	Requirement of FAT and DCHS protocadherins during hypothalamic-pituitary development.	DCHS2 POU1F1 TBX19	5.09e-05	18	141	3	33108146
Pubmed	The chromosomal location of the mouse mammary tumor gene Int6 and related pseudogenes in the mouse genome.	FNDC3A MET CD74	6.03e-05	19	141	3	7558022
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	ATP5PB MAPK8IP1 ATXN2L FLNA CDC42BPA MAP1A PDK3 ACO2 BACH1 GRIN1 MET ARHGEF7 IQSEC1 NAV1 SMARCC2	6.37e-05	1139	141	15	36417873
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	ATP5PB HNF1A DENND4A HTR1E QPCTL SAMD4B PFAS GPATCH8 LYAR MET RASGRP1 CNOT6L ARHGEF7 MORF4L1 RAD54B KIF5C	6.88e-05	1284	141	16	17353931
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	TTF2 TMEM201 KMT2B RTCB BACH1 TLX3 GATA2 GPATCH8 LYAR IFI16 TOX4 UBN1 NFIA MORF4L1 KMT2A FOXC1	7.53e-05	1294	141	16	30804502
Pubmed	Reciprocal interactions of Pit1 and GATA2 mediate signaling gradient-induced determination of pituitary cell types.	GATA2 POU1F1 FOXC1	8.22e-05	21	141	3	10367888
Pubmed	Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition.	KMT2B KMT2E KMT2A	8.22e-05	21	141	3	27626377
Pubmed	ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation.	MLLT10 KMT2A SMARCC2	8.22e-05	21	141	3	12453419
Pubmed	Recruitment of the Mammalian Histone-modifying EMSY Complex to Target Genes Is Regulated by ZNF131.	KMT2B GPATCH8 MORF4L1 KMT2A LTBP1	8.87e-05	110	141	5	26841866
Pubmed	The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA.	ATXN2L TTF2 HSPG2 LYAR IFI16 COL18A1 UBN1 FOXC1	9.44e-05	349	141	8	25665578
Pubmed	Structural basis for activity regulation of MLL family methyltransferases.	KMT2B KMT2E KMT2A	9.49e-05	22	141	3	26886794
Pubmed	Analysis of gene rearrangements using a fluorescence in situ hybridization method in Mexican patients with acute lymphoblastic leukemia: experience at a single institution.	ETV6 KMT2A	9.74e-05	4	141	2	18617057
Pubmed	IFI16 induction by glucose restriction in human fibroblasts contributes to autophagy through activation of the ATM/AMPK/p53 pathway.	IFI16 ATM	9.74e-05	4	141	2	21573174
Pubmed	Cross-talk between histone modifications in response to histone deacetylase inhibitors: MLL4 links histone H3 acetylation and histone H3K4 methylation.	KMT2B KMT2A	9.74e-05	4	141	2	17166833
Pubmed	WDR5 interacts with mixed lineage leukemia (MLL) protein via the histone H3-binding pocket.	KMT2B KMT2A	9.74e-05	4	141	2	18840606
Pubmed	GRIF-1 and OIP106, members of a novel gene family of coiled-coil domain proteins: association in vivo and in vitro with kinesin.	TRAK1 KIF5C	9.74e-05	4	141	2	15644324
Pubmed	TRIM24 is a p53-induced E3-ubiquitin ligase that undergoes ATM-mediated phosphorylation and autodegradation during DNA damage.	TRIM33 ATM	9.74e-05	4	141	2	24820418
Pubmed	MED220/thyroid receptor-associated protein 220 functions as a transcriptional coactivator with Pit-1 and GATA-2 on the thyrotropin-beta promoter in thyrotropes.	GATA2 POU1F1	9.74e-05	4	141	2	16396960
Pubmed	Aven recognition of RNA G-quadruplexes regulates translation of the mixed lineage leukemia protooncogenes.	KMT2B KMT2A	9.74e-05	4	141	2	26267306
Pubmed	Subendothelial heparan sulfate proteoglycans become major L-selectin and monocyte chemoattractant protein-1 ligands upon renal ischemia/reperfusion.	HSPG2 COL18A1	9.74e-05	4	141	2	17525255
Pubmed	Semaphorin 5A promotes angiogenesis by increasing endothelial cell proliferation, migration, and decreasing apoptosis.	SEMA5A MET	9.74e-05	4	141	2	19850054
Interaction	TOP3B interactions	HSPG2 FLNA FAM193B LZTR1 CDC42BPA KMT2B SH3RF1 SAMD4B MKRN2 L1CAM KSR2 GATA2 PFAS TNRC6C MLLT10 LYAR IFNLR1 TRAK1 TRAF4 C2CD3 CNOT6L UBN1 ZNRF3 NBEAL2 NAV1 FLCN UNKL PLA2G6 PKN1 DTX2 PRDM16 ARAP1	2.35e-09	1470	136	32	int:TOP3B
Interaction	ATXN1L interactions	HNF1A ELP5 ACO2 TLX3 GATA2 GPATCH8 NFIA SMARCC2 UNKL	8.26e-07	150	136	9	int:ATXN1L
Interaction	TLE3 interactions	ZNF703 FLNA TLX3 GATA2 ETV6 ZNF362 GPATCH8 MLLT10 NFIA AUTS2 KMT2A SMARCC2 FOXC1	1.65e-06	376	136	13	int:TLE3
Interaction	ARID3A interactions	HNF1A TLX3 GATA2 BCAR1 NFIA MORF4L1 FOXC1	1.92e-05	122	136	7	int:ARID3A
Interaction	CEP85 interactions	SAMD4B MKRN2 ETV6 TNRC6C TRAF4 CNOT6L FBXO42 DTX2	1.96e-05	169	136	8	int:CEP85
Interaction	NCOA3 interactions	HNF1A TLX3 GATA2 STAT6 TRIM33 NFIA SMARCC2 MYOCD DTX2	2.18e-05	224	136	9	int:NCOA3
Interaction	YWHAE interactions	UBR2 ATXN2L FLNA HNF1A DENND4A CDC42BPA SH3RF1 QPCTL SAMD4B WASF3 KSR2 BCAR1 TRAK1 MAST4 ARHGEF7 NAV1 KMT2A SMARCC2 CD74 LTBP1 HSF1 FOXC1	3.46e-05	1256	136	22	int:YWHAE
Interaction	FOXI1 interactions	ZNF703 MLLT10 TRIM33 NFIA DTX2 FOXC1	3.75e-05	92	136	6	int:FOXI1
Interaction	ZNF608 interactions	KMT2B TLX3 GATA2 NFIA AUTS2 KMT2A	3.98e-05	93	136	6	int:ZNF608
Interaction	DCAF7 interactions	ZNF703 FLNA QPCTL BACH1 TLX3 GATA2 TRIM33 PTPN7 AUTS2 HSF1 ZNF574	4.12e-05	368	136	11	int:DCAF7
Interaction	NFIB interactions	MKRN2 TLX3 GATA2 ETV3 NFIA DTX2 FOXC1	5.09e-05	142	136	7	int:NFIB
Interaction	SFN interactions	ATXN2L DENND4A CDC42BPA SH3RF1 MAP1A BACH1 BCAR1 TRAK1 MET MAST4 NFIA TRIM62 NAV1 KMT2A DTX2	6.90e-05	692	136	15	int:SFN
Interaction	CHD7 interactions	MKRN2 TLX3 GATA2 ETV3 BCAR1 FBXO42 SMARCC2	7.20e-05	150	136	7	int:CHD7
Interaction	TRIO interactions	FLNA MKRN2 PTPRD ARHGEF7 NAV1 PRDM16	9.69e-05	109	136	6	int:TRIO
Interaction	TPSAB1 interactions	TPSAB1 ATM TPSB2	1.04e-04	14	136	3	int:TPSAB1
Interaction	SATB2 interactions	MKRN2 TLX3 GATA2 TBX19 TFCP2L1 NFIA FOXC1	1.04e-04	159	136	7	int:SATB2
Interaction	KDM6A interactions	HNF1A KMT2B TLX3 GATA2 NFIA KMT2A ATM	1.17e-04	162	136	7	int:KDM6A
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	KMT2B KMT2E KMT2A PRDM16	2.08e-05	34	87	4	487
GeneFamily	PHD finger proteins	KMT2B MLLT10 KMT2E TRIM33 KMT2A	7.32e-05	90	87	5	88
GeneFamily	Ring finger proteins	SH3RF1 MKRN2 TRIM33 TRAF4 ZNRF3 TRIM62 DTX2	3.61e-04	275	87	7	58
GeneFamily	Zinc fingers CXXC-type	KMT2B KMT2A	1.46e-03	12	87	2	136
Coexpression	GSE24671_CTRL_VS_SENDAI_VIRUS_INFECTED_MOUSE_SPLENOCYTES_DN	TRABD2B L1CAM TNRC6C CNOT6L CASTOR1 NFIA C8orf82 ZNF574 ZNF292	1.30e-06	199	140	9	M9443
Coexpression	GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN	CDC42BPA STXBP5 TNRC6C TRAK1 C2CD3 PTPRD NAV1 PLA2G6	3.21e-06	166	140	8	M6826
Coexpression	BUSSLINGER_DUODENAL_IMMUNE_CELLS	ATXN2L FLNA TNRC6C KMT2E IFI16 RASGRP1 PTPN7 CNOT6L GVINP1 NBEAL2 MORF4L1 AUTS2 KMT2A PKN1 ATM TPSB2 ZNF292	7.71e-06	911	140	17	M40038
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	UBR2 CDC42BPA WASF3 SEMA5A FNDC3A ZNF804A TRAK1 TRIM33 C2CD3 ARHGEF7 KIF5C ZNF292	8.09e-06	466	140	12	M13522
Coexpression	GRESHOCK_CANCER_COPY_NUMBER_UP	HNF1A TLX3 ETV6 MLLT10 TRIM33 MET FLCN KMT2A ATM PRDM16	9.81e-06	323	140	10	M9150
Coexpression	GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN	BACH1 ETV3 TNRC6C TRAK1 STAT6 CD27 AUTS2 ATM	1.01e-05	194	140	8	M7306
Coexpression	GSE5679_PPARG_LIGAND_ROSIGLITAZONE_VS_ROSIGLITAZONE_AND_RARA_AGONIST_AM580_TREATED_DC_DN	DENND4A CYP2D6 ETV3 RASGRP1 DGLUCY TRAF4 CAMTA1 REV1	1.26e-05	200	140	8	M6567
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	UBR2 TPSAB1 ATXN2L FLNA DENND4A GATA2 TNRC6C GPATCH8 KMT2E IFI16 TRIM33 RASGRP1 PTPN7 CNOT6L GVINP1 CD27 NBEAL2 AUTS2 KMT2A ATM TPSB2 ZNF292	1.41e-05	1492	140	22	M40023
Coexpression	MARTINEZ_RB1_AND_TP53_TARGETS_DN	ATXN2L FLNA SH3RF1 CD248 BACH1 POU1F1 LYAR COL18A1 NFIA LTBP1 ATM FOXC1 ZNF574	2.50e-05	610	140	13	M3854
Coexpression	MARTINEZ_TP53_TARGETS_DN	ATXN2L FLNA SH3RF1 CD248 BACH1 POU1F1 LYAR IFI16 COL18A1 NFIA ATM FOXC1 ZNF574	2.72e-05	615	140	13	M8673
Coexpression	GSE6269_FLU_VS_E_COLI_INF_PBMC_UP	KMT2B GPATCH8 IFI16 ZBP1 C2CD3 NBEAL2 CD74	2.95e-05	164	140	7	M5653
Coexpression	KUMAR_TARGETS_OF_MLL_AF9_FUSION	CYP2D6 ZNF362 IFI16 SHD TRAF4 CD27 NAV1 KMT2A ATM KLK2 RECK	4.08e-05	463	140	11	MM1011
Coexpression	MARTINEZ_RB1_AND_TP53_TARGETS_DN	ATXN2L FLNA SH3RF1 CD248 BACH1 POU1F1 LYAR COL18A1 NFIA LTBP1 ATM FOXC1 ZNF574	4.79e-05	650	140	13	MM1042
Coexpression	ODONNELL_METASTASIS_UP	GATA2 ONECUT1 NFIA ARHGEF7 BBC3	5.51e-05	76	140	5	M265
Coexpression	LIM_MAMMARY_STEM_CELL_UP	LARGE2 HSPG2 TMEM201 ELP5 BACH1 SEMA5A BCAR1 COL18A1 SULF1 MYOCD RECK	5.53e-05	479	140	11	M2573
Coexpression	LIM_MAMMARY_STEM_CELL_UP	LARGE2 HSPG2 TMEM201 ELP5 BACH1 SEMA5A BCAR1 COL18A1 SULF1 MYOCD RECK	5.96e-05	483	140	11	MM1082
Coexpression	CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN	SEMA5A FNDC3A BCAR1 FAAH MET FREM2 PTPRD NFIA CAMTA1 FOXC1	6.98e-05	407	140	10	M2214
Coexpression	KUMAR_TARGETS_OF_MLL_AF9_FUSION	CYP2D6 ZNF362 IFI16 SHD TRAF4 CD27 NAV1 KMT2A ATM RECK	7.12e-05	408	140	10	M3284
Coexpression	GSE17721_0.5H_VS_24H_POLYIC_BMDC_DN	PDK3 ETV3 MLLT10 KMT2E ZBP1 IQSEC1 ZNF574	1.00e-04	199	140	7	M4097
Coexpression	GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_UP	L1CAM CUBN ONECUT1 TRAF4 KMT2A DTX2 REV1	1.03e-04	200	140	7	M4016
Coexpression	GSE360_L_DONOVANI_VS_L_MAJOR_DC_UP	ATXN2L POU1F1 GRIN1 FCGBP NFIA KMT2A BBC3	1.03e-04	200	140	7	M5192
Coexpression	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	UBR2 FNDC3A ZNF804A TRAK1 AUTS2 SMARCC2 KIF5C	1.24e-04	206	140	7	M2817
Coexpression	GSE45365_NK_CELL_VS_BCELL_DN	LARGE2 DENND4A LYAR CD27 PLA2G6 TPSB2	1.32e-04	145	140	6	M10023
Coexpression	STARK_PREFRONTAL_CORTEX_22Q11_DELETION_UP	UBR2 FNDC3A ZNF804A TRAK1 AUTS2 SMARCC2 KIF5C	1.32e-04	208	140	7	MM581
Coexpression	HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN	FNDC3A PFAS IFI16 ZNF804A STAT6 SULF1 AUTS2 FAM149A	1.43e-04	282	140	8	M7623
Coexpression	LAKE_ADULT_KIDNEY_C2_PODOCYTES	SH3RF1 BACH1 SEMA5A ZNF804A PTPRD ZNRF3 SULF1	1.48e-04	212	140	7	M39221
Coexpression	BROWNE_HCMV_INFECTION_1HR_UP	POU1F1 ONECUT1 RASGRP1 NFIA	1.60e-04	51	140	4	M5823
Coexpression	PUJANA_ATM_PCC_NETWORK	ATP5PB UBR2 TTF2 HNF1A HTR1E ETV6 POU1F1 PFAS IFI16 ONECUT1 ZNF804A RASGRP1 PTPN7 UBN1 NFIA NBEAL2 PKN1 ATM RECK	1.61e-04	1394	140	19	M9585
Coexpression	HOEBEKE_LYMPHOID_STEM_CELL_UP	UBR2 TRIM33 TRAF4 IQSEC1 C11orf21	1.76e-04	97	140	5	M14698
Coexpression	BENPORATH_ES_CORE_NINE_CORRELATED	ETV6 TBX19 TFCP2L1 HSF1 FOXC1	2.03e-04	100	140	5	M14079
Coexpression	THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_VS_70PLS_0DY_UP	CD248 FCGBP IQSEC1	2.13e-04	22	140	3	M40867
Coexpression	MARTINEZ_TP53_TARGETS_DN	ATXN2L FLNA SH3RF1 CD248 BACH1 POU1F1 LYAR COL18A1 NFIA ATM FOXC1 ZNF574	2.25e-04	659	140	12	MM1040
Coexpression	MARTINEZ_RB1_TARGETS_DN	TPSAB1 FLNA CD248 POU1F1 LYAR IFI16 COL18A1 NFIA CTF1 LTBP1 ZNF574	2.49e-04	569	140	11	M12701
Coexpression	ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN	TMEM201 ZNF362 ZNRF3 NFIA AUTS2	2.66e-04	106	140	5	M9160
Coexpression	BORCZUK_MALIGNANT_MESOTHELIOMA_DN	TPSAB1 MAST4 NFIA NBEAL2 ARAP1	2.66e-04	106	140	5	M7988
ToppCell	NS-critical-d_0-4-Lymphoid-CTL\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TNRC6C RASGRP1 PTPN7 CNOT6L CD27 AUTS2 KMT2A ATM KIF5C	9.18e-09	189	140	9	fb7572fb4c7c43886d57a025decad076f32a14c4
ToppCell	Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	HSPG2 CDC42BPA MAP1A CD248 SSC5D NFIA SULF1 LTBP1 FOXC1	1.44e-08	199	140	9	40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a
ToppCell	Pericytes-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	ZNF703 TRABD2B MAP1A CD248 SEMA5A COL18A1 MYOCD LTBP1	1.21e-07	183	140	8	4617b18da8d699a44e4c47980197b1e7eb951470
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway-epi_proximal_progenitor1_(6)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	KSR2 IRX1 MET FREM2 ZNF804B KIF5C PRDM16 FAM149A	1.56e-07	189	140	8	7659c7bbd58ee959a159294fb8d17317bbcc5681
ToppCell	NS-critical-d_0-4-Lymphoid\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TNRC6C RASGRP1 PTPN7 CNOT6L CD27 AUTS2 KMT2A ATM	1.62e-07	190	140	8	84f9f5ac29ff0f929a589b76efa61d4c570e76b0
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNA MAP1A SEMA5A COL18A1 NFIA MYOCD LTBP1 FOXC1	1.75e-07	192	140	8	26d9207e72bbef5e0046de511e2c9ff752b726f3
ToppCell	PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LARGE2 KSR2 IRX1 MET FREM2 ZNF804B PRDM16 FAM149A	1.75e-07	192	140	8	b99f8236ef4ccdc75c02abea381cae6453205f6f
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	TRABD2B SH3RF1 CUBN MET TFCP2L1 MAST4 PTPRD ZNRF3	1.90e-07	194	140	8	7002937e8903e037332a215d00fbc7c7843b33f2
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	TRABD2B SH3RF1 MET COL18A1 FREM2 TFCP2L1 MAST4 ZNRF3	1.90e-07	194	140	8	5eaaa81f4b2535f983c424aaef00077089526a5c
ToppCell	Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_arterial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	HSPG2 CDC42BPA GATA2 MET MAST4 SULF1 PURG FOXC1	2.31e-07	199	140	8	6a2943a23fdd2ec814662db7c21a0d6804a6cbbc
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FLNA MAP1A ARHGEF7 SULF1 MYOCD LTBP1 NPAS4 FOXC1	2.40e-07	200	140	8	9169a9ec8e9ab95d90a64c5a19ac666a5cf82313
ToppCell	Control_saline-Endothelial-Endothelial-Vein\|Control_saline / Treatment groups by lineage, cell group, cell type	HSPG2 GATA2 IFI16 FAM221B COL18A1 NFIA LTBP1 FOXC1	2.40e-07	200	140	8	e5f876910bc8cb390d9b46a48d9b6d4d57235551
ToppCell	PND07-Immune-Immune_Myeloid-Granulocytic-Mast-Mast_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TPSAB1 L1CAM KSR2 GATA2 PTPN7 NAV1 TPSB2	7.62e-07	160	140	7	5d22c86deead516444349d495998e04586be4396
ToppCell	PND07-Immune-Immune_Myeloid-Granulocytic-Mast\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TPSAB1 L1CAM KSR2 GATA2 PTPN7 NAV1 TPSB2	7.62e-07	160	140	7	ca212634cf1875238071d1800ecdf34979a553fb
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)\|Adult / Lineage, Cell type, age group and donor	MET TRAF4 TFCP2L1 MAST4 AUTS2 PRDM16 FAM149A	8.63e-07	163	140	7	e819a1d6d28290854aa0672b3a18fa9e293d8f23
ToppCell	368C-Myeloid-Dendritic-pDC\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	MAP1A PFAS IFNLR1 FAAH SHD TRAF4 ZNF469	1.19e-06	171	140	7	714a0b0d0c9886fef64170cf53eb64f0d8a47280
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HNF1A TRABD2B SEMA5A CUBN MAST4 PTPRD ZNF804B	1.74e-06	181	140	7	9542c19edc9bd2cba68c01c2a8407705398e3011
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HNF1A TRABD2B SEMA5A CUBN MAST4 PTPRD ZNF804B	1.74e-06	181	140	7	8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	SH3RF1 MET FREM2 TFCP2L1 MAST4 PTPRD FAM149A	1.74e-06	181	140	7	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAM47A FLNA CBLL2 FREM2 MYOCD LTBP1 NPAS4	2.16e-06	187	140	7	3912bbb610a4a84791e9bda92a2d57a52c31d29e
ToppCell	PCW_10-12-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	LARGE2 KSR2 IRX1 FREM2 TFCP2L1 ZNF804B PRDM16	2.24e-06	188	140	7	3cfba3addcc9058f4ec31ad96261f79988f551a0
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Artery\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	HSPG2 SULF1 CNTNAP4 NAV1 LTBP1 PRDM16 FOXC1	2.40e-06	190	140	7	aed65d584ca0c25f6a8313c66b421a6618af82ea
ToppCell	droplet-Kidney-nan-21m-Epithelial-kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1A CD248 ZNF804A SULF1 MYOCD LTBP1 FOXC1	2.40e-06	190	140	7	1803b1e7c36285f9eaabc3c6e9a9752c5908db3d
ToppCell	PCW_05-06-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	LARGE2 KSR2 IRX1 MET FREM2 PRDM16 FAM149A	2.48e-06	191	140	7	05731ece7867659c662f952812805f947032fe10
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MET FREM2 TFCP2L1 MAST4 PTPRD ZNRF3 AUTS2	2.48e-06	191	140	7	a0332a4ef629510fb313ec119195c44a3f704a80
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SH3RF1 MET FREM2 MAST4 ZNRF3 AUTS2 PRDM16	2.48e-06	191	140	7	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	390C-Myeloid-Mast_cell\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	TPSAB1 STXBP5 GATA2 COL18A1 PTPN7 MAST4 TPSB2	2.57e-06	192	140	7	201d430af1e4fee7bc03baf0aca17db26f6f439a
ToppCell	390C-Myeloid-Mast_cell-\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	TPSAB1 STXBP5 GATA2 COL18A1 PTPN7 MAST4 TPSB2	2.57e-06	192	140	7	15c1a0a0d07106118427135f166a1da710bf621a
ToppCell	PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNA MAP1A SEMA5A COL18A1 NFIA MYOCD FOXC1	2.66e-06	193	140	7	9a2c1711dec9dd8c8313bcf25bb888ac8e86c3f3
ToppCell	PCW_05-06-Epithelial-Epithelial_neuroendo\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	LARGE2 KSR2 IRX1 MET FREM2 KIF5C FAM149A	2.66e-06	193	140	7	aa10924b203c71e65fdbd2b90ba131dbd362d8b1
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNA MAP1A SEMA5A COL18A1 NFIA MYOCD FOXC1	2.66e-06	193	140	7	7fc3ab7261c88c1df71744bf5b17e8e46c4300e0
ToppCell	PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLNA MAP1A SEMA5A COL18A1 NFIA MYOCD FOXC1	2.66e-06	193	140	7	7c7aa5e2124830d0fa1df11b6413ec6cf780aad0
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SH3RF1 MET FREM2 TFCP2L1 MAST4 PTPRD AUTS2	2.75e-06	194	140	7	97534c8bba895a7913665e03ae4e5c4a6ad71daf
ToppCell	PCW_07-8.5-Epithelial\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	LARGE2 KSR2 IRX1 FREM2 ZNF804B KIF5C PRDM16	2.75e-06	194	140	7	f63ceedb88a9abc8644ee94adfd541e7817c1e3a
ToppCell	PCW_07-8.5-Epithelial-Epithelial_airway\|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung	IRX1 MET FREM2 ZNF804B KIF5C PRDM16 FAM149A	2.75e-06	194	140	7	f95c8dc242c9aebcadfe61b1ed033349cb7e5a88
ToppCell	erythropoietic-CD34+_Pro-erythroblast\|erythropoietic / Lineage and Cell class	TPSAB1 HSPG2 GATA2 ETV6 IFI16 CD74 TPSB2	2.85e-06	195	140	7	cd3d8fa6e18c0508cdfb64bb879d90b211badee5
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	HTR1E SH3RF1 MET MAST4 PTPRD PRDM16 FAM149A	2.85e-06	195	140	7	dccc32fcf772e2504de7f663ef0a5bd8e23e92fc
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNRC6C GPATCH8 ZBP1 RASGRP1 PTPN7 CD27 ATM	2.95e-06	196	140	7	a9157809122e6fc5783a291522f103bef30943e4
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-Pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNA TRABD2B CD248 COL18A1 ARHGEF7 MYOCD LTBP1	2.95e-06	196	140	7	184104cbea0461dd2757668ab9755948ac7b585a
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNA TRABD2B CD248 COL18A1 ARHGEF7 MYOCD LTBP1	2.95e-06	196	140	7	bebb20dc210576101c317011e3afb59798f5d255
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Mesenchymal-brain_pericyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNA TRABD2B CD248 COL18A1 ARHGEF7 MYOCD LTBP1	2.95e-06	196	140	7	8114e98923096c54b6834f21550c3061bab6773d
ToppCell	Fibroblasts-DKK3+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	HSPG2 CDC42BPA MAP1A SSC5D PTPRD SULF1 LTBP1	3.15e-06	198	140	7	4f4632f26a2043c5e4ab89031b4229b5dca1bd48
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MET FREM2 TFCP2L1 MAST4 PTPRD ZNRF3 AUTS2	3.15e-06	198	140	7	2e2a4e1756bba6f4fbe529559a97d2993c890b4b
ToppCell	Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD3-NKT\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	LYAR ZBP1 RASGRP1 PTPN7 CNOT6L C11orf21 ATM	3.37e-06	200	140	7	846d3f0e647040d0e372df0dfcd69a21d5da5aea
ToppCell	mild-CD8+_Tem\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	FLNA LYAR ZBP1 RASGRP1 CNOT6L KMT2A ATM	3.37e-06	200	140	7	d8aec4904c9420b8f9d7508658ba1e36c66cdfcc
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte-Pericyte_3\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FLNA MAP1A COL18A1 ARHGEF7 MYOCD LTBP1 FOXC1	3.37e-06	200	140	7	a3a1e35934d676c39f917652e50c502cb2f613c1
ToppCell	Tracheal-10x3prime_v2-Immune_Lymphocytic-T-T_CD3\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	LYAR ZBP1 RASGRP1 PTPN7 CNOT6L C11orf21 ATM	3.37e-06	200	140	7	c70f06b243ae9804f97308ee02b4b5e1a4a6f9f3
ToppCell	mild-gd_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	LYAR RASGRP1 TFCP2L1 CNOT6L AUTS2 KMT2A ATM	3.37e-06	200	140	7	109f673a4967ffa52270a0b4f818b3461288db44
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Artery\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	GATA2 MET COL18A1 MAST4 SULF1 LTBP1 FOXC1	3.37e-06	200	140	7	ac9ead34afa14067171833f5c277eaf06db7b02e
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-1m-Neuronal-Interneuron\|1m / Sample Type, Dataset, Time_group, and Cell type.	DCHS2 L1CAM GATA2 ONECUT1 ZNF804A SHD KIF5C	3.37e-06	200	140	7	fc839e9c33ea1d4ee0f42f21fd32a54e7cbe1f5a
ToppCell	TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Rectal_Adenocarcinoma\|TCGA-Colorectal / Sample_Type by Project: Shred V9	KSR2 ETV6 GRIN1 FAM221B FCGBP KLK2	5.00e-06	138	140	6	e1e936ff4080bda2810c5fd1154a706359f377a5
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DENND4A TLX3 NBEAL2 KIF5C PURG ARAP1	5.00e-06	138	140	6	6b83c434895d82eaf3c222eef27acec76f9c0a77
ToppCell	control-dn_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ATP5PB CD248 LYAR MET RASGRP1 CD27	7.19e-06	147	140	6	68258498202c7f580f72c46dd645071835098455
ToppCell	343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1\|343B / Donor, Lineage, Cell class and subclass (all cells)	NPIPB11 LYAR ZBP1 PTPN7 CD27 ATM	7.77e-06	149	140	6	2a7f71da51c85e04de2123164914122480e60d66
ToppCell	PND03-Immune-Immune_Myeloid-Granulocytic-Mast\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TPSAB1 L1CAM KSR2 GATA2 PTPN7 TPSB2	8.38e-06	151	140	6	9702575e47ececcf0a9f0f20a4a920dbb1ba5657
ToppCell	PND03-Immune-Immune_Myeloid-Granulocytic-Mast-Mast_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	TPSAB1 L1CAM KSR2 GATA2 PTPN7 TPSB2	8.38e-06	151	140	6	673e4ab117b723c14d1df3804bbedc9e48284a9d
ToppCell	10x5'-bone_marrow-Mast\|bone_marrow / Manually curated celltypes from each tissue	TPSAB1 HSPG2 CDC42BPA GATA2 TPSB2 PURG	1.13e-05	159	140	6	c3d3570e83c5d25cc92fa3a7a8f0dc2f89a72913
ToppCell	10x5'-bone_marrow-Mast-Mast_cells\|bone_marrow / Manually curated celltypes from each tissue	TPSAB1 HSPG2 CDC42BPA GATA2 TPSB2 PURG	1.21e-05	161	140	6	15ba7e69699558353cfeecdcf1dbc2e147379ed6
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c04-COTL1\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	FLNA LYAR ZBP1 TRIM33 AUTS2 CD74	1.21e-05	161	140	6	bf4bfb416cb6ef43fc8cf0ffc2d7f0b6b42ab4da
ToppCell	Fetal_29-31_weeks-Immune-mast_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	TPSAB1 STXBP5 GATA2 ZNF804A C11orf21 TPSB2	1.30e-05	163	140	6	03b2ec226adffba3ce893f3d12e549c841e662fd
ToppCell	wk_20-22-Hematologic-Myeloid-Mast\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	TPSAB1 STXBP5 GATA2 LYAR SHD TPSB2	1.44e-05	166	140	6	004ab6a1425d812c7ce572205875fd702d4a9659
ToppCell	3'-Parenchyma_lung-Immune_Myeloid_mast-Myeloid_Mast/Baso-mast_cell-Mast_cells-Mast_cells_L.1.4.3.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	TPSAB1 GATA2 ETV3 SSC5D PTPN7 TPSB2	1.54e-05	168	140	6	55f328353119cbdc521c782ebb8d163876f4186d
ToppCell	NS-critical-d_0-4-Epithelial-Secretory\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	HSPG2 CYP2D6 FAAH MET TFCP2L1 FCGBP	1.59e-05	169	140	6	aec97583b23112060437b619cb429dc32f29285f
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SH3RF1 MET TRAF4 MAST4 AUTS2 PRDM16	1.64e-05	170	140	6	a2c738e441ced90eeeb1fcc6ca3269b918aaa298
ToppCell	368C-Myeloid-Monocyte-CD16+_Monocyte\|Monocyte / Donor, Lineage, Cell class and subclass (all cells)	IRX1 BCAR1 IFNLR1 RASGRP1 MAST4 CTF1	1.64e-05	170	140	6	4a19c7e3bb0f9c2601a10debe7000066789b4150
ToppCell	control-Myeloid-Eosinophils\|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	TPSAB1 CDC42BPA GATA2 POU1F1 PLA2G6 TPSB2	1.70e-05	171	140	6	82f736c33ed96c0865618e8f8eb82a5487126bdc
ToppCell	wk_20-22-Hematologic-Myeloid-Eosinophil\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	TPSAB1 GATA2 LYAR ZNF804A SHD TPSB2	1.70e-05	171	140	6	fa6e856e62b82ec4972e0098e73f237cc611891f
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HNF1A FREM2 PTPRD SULF1 LTBP1 KIF5C	1.82e-05	173	140	6	30d67738633493d47f06ae452424382f069b6c0a
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_1_/_Segment_2\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HNF1A TRABD2B CUBN MAST4 PTPRD ZNF804B	1.82e-05	173	140	6	8888434641ea554a9b62c436e87920378eef29cd
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HNF1A FREM2 PTPRD SULF1 LTBP1 KIF5C	1.88e-05	174	140	6	a9c6edf5c3fc119c24425f921c5566a8356c30fe
ToppCell	COVID-19-kidney-Podocyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SEMA5A ZNF804A PTPRD ZNRF3 SULF1 FOXC1	1.94e-05	175	140	6	a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223
ToppCell	Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)\|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	DCHS2 HTR1E ZNF804A RASGRP1 NFIA ZNF804B	2.13e-05	178	140	6	b169aa5eaa51730daaec69c6bc58126be1592a50
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_3\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	SH3RF1 NPIPB11 TBX19 TRIM33 PLA2G6 LTBP1	2.13e-05	178	140	6	9d575902d3dbe33437c9d4200df093a741269803
ToppCell	ASK440-Immune-Mast_cell\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	TPSAB1 ATG9B STXBP5 GATA2 PTPN7 NAV1	2.13e-05	178	140	6	dcefc4afca3a40d1bd44722e66bca6b45a6c6c55
ToppCell	PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PFAS MET PTPN7 TRAF4 RAD54B CD74	2.20e-05	179	140	6	9dea57494d59abd6e8abf34e31faf53462ea0fa0
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	HNF1A TRABD2B SEMA5A CUBN MAST4 ZNF804B	2.20e-05	179	140	6	d1ef7e1cb00336118e387b47f4f8120f53584391
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRABD2B SEMA5A CUBN MET PTPRD ZNF804B	2.20e-05	179	140	6	58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428
ToppCell	COVID-19-Heart-VSMC\|Heart / Disease (COVID-19 only), tissue and cell type	FLNA TRABD2B COL18A1 ARHGEF7 MYOCD PRDM16	2.20e-05	179	140	6	a69ad6912b5c10bb9f9d800f724c792341e9bab1
ToppCell	3'_v3-bone_marrow-Mast\|bone_marrow / Manually curated celltypes from each tissue	TPSAB1 HSPG2 CDC42BPA GATA2 LTBP1 TPSB2	2.27e-05	180	140	6	b37ee81b792213d6595b4ec65d04bc35d83321c7
ToppCell	3'_v3-bone_marrow-Mast-Mast_cells\|bone_marrow / Manually curated celltypes from each tissue	TPSAB1 HSPG2 CDC42BPA GATA2 LTBP1 TPSB2	2.34e-05	181	140	6	30ec4635474ee0f0ea1415ec0ba7f008d97e8c1a
ToppCell	3'_v3-blood-Myeloid_Dendritic-pDC\|blood / Manually curated celltypes from each tissue	MAP1A SEMA5A GRIN1 SHD TRAF4 CD74	2.34e-05	181	140	6	66d890a105f955dca91d6e5e6c730d1a68ee9233
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TRABD2B SH3RF1 KSR2 RASGRP1 FREM2 PRDM16	2.34e-05	181	140	6	aa233b652921848af2257cc3687a7a09c3acfb67
ToppCell	tumor_Lung-Myeloid_cells-pDCs\|tumor_Lung / Location, Cell class and cell subclass	MAP1A CBLL2 ETV3 FAM221B SHD TRAF4	2.34e-05	181	140	6	c864ffeb9234b8c29754afc91c85a972889617f4
ToppCell	COPD-Epithelial-Basal\|World / Disease state, Lineage and Cell class	SH3RF1 SEMA5A MET MAST4 SULF1 NTM-AS1	2.34e-05	181	140	6	6d8a886b4afe729f8a05b9c0f4ea9375de735da4
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-Myeloid-pDC\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MAP1A GRIN1 FAM221B SHD TRAF4 CD74	2.42e-05	182	140	6	02c0824373a0ecebc922d4ca848ace9d570722c4
ToppCell	Children_(3_yrs)-Epithelial-club_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	HTR1E MET TRAF4 PTPRD DTX2 FAM149A	2.42e-05	182	140	6	215c303df42f13597b2c7a95cb157c6bc7aca9a1
ToppCell	COVID-19-kidney-Distal_Epi_Doublet_(PCT)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	TRABD2B CUBN MET TFCP2L1 ZNF804B FAM149A	2.42e-05	182	140	6	9d67717a6e13bcb54c1297a3e4e3abf4e51628a3
ToppCell	hematopoetic_progenitors-CD34+_MEP_2\|World / Lineage and Cell class	TPSAB1 HSPG2 GATA2 ZNF804A LTBP1 TPSB2	2.42e-05	182	140	6	a7e7aa10f14111a6c7ba22e0f1668dcaa124714d
ToppCell	Basal\|World / shred by cell class for mouse tongue	LARGE2 TRABD2B COL18A1 FREM2 MORF4L1 LTBP1	2.49e-05	183	140	6	c6729a207526ff4aa48176207b9353176f631fea
ToppCell	COPD-Epithelial-ATII\|World / Disease state, Lineage and Cell class	SH3RF1 MET FREM2 TFCP2L1 MAST4 AUTS2	2.49e-05	183	140	6	8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9
ToppCell	CTRL-Myeloid-cDC\|CTRL / Disease state, Lineage and Cell class	WASF3 ETV3 ZNF469 AUTS2 NAV1 FAM149A	2.49e-05	183	140	6	20c4d16de7e090df3556a4458f783383a26871b6
ToppCell	COVID-19-kidney-PCT-S1\|kidney / Disease (COVID-19 only), tissue and cell type	SEMA5A CUBN MAST4 PTPRD NFIA ZNF804B	2.57e-05	184	140	6	51ed1ebfdef45149541917c66cbacad87072e51f
ToppCell	normal_Lung-Fibroblasts-Myofibroblasts\|normal_Lung / Location, Cell class and cell subclass	CD248 SSC5D ZNF469 PTPRD SULF1 LTBP1	2.57e-05	184	140	6	0b336489c10e8c3c957795dd845454f03404382b
ToppCell	droplet-Marrow-nan-3m-Lymphocytic-late_pro-B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	QPCTL FNDC3A CUBN FAAH ZNRF3 CD74	2.57e-05	184	140	6	42cadfdb5d29a50bd7e901ddd14d42b39e8474f0
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TNRC6C RASGRP1 CNOT6L CD27 KMT2A ATM	2.57e-05	184	140	6	5350b58aa9979631228835d11eb45ddf81d08bff
ToppCell	COVID-19_Moderate-HSPC\|World / disease group, cell group and cell class	TPSAB1 CDC42BPA GATA2 PTPRD TPSB2 PURG	2.57e-05	184	140	6	ccc93babe1fcdeb66b78e1d8414357877a7c45bd
ToppCell	Leuk-UTI-Other-RBC\|Leuk-UTI / Disease, Lineage and Cell Type	MAP1A GRIN1 FAM221B SHD TRAF4 CD74	2.65e-05	185	140	6	5b5dd856d6efc0539d92533cff134bbc3f98be45
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SH3RF1 MET MAST4 AUTS2 PRDM16 FAM149A	2.65e-05	185	140	6	98b8ee42b89d97e4c9db01740e0c193503c68f2c
ToppCell	COVID-19-Epithelial_cells-Airway_club\|COVID-19 / group, cell type (main and fine annotations)	MET MAST4 PTPRD NFIA PRDM16 FAM149A	2.65e-05	185	140	6	cfe6fd73d817e173fe803bc1683c291d9bcb8608
ToppCell	Leuk-UTI-Other\|Leuk-UTI / Disease, Lineage and Cell Type	MAP1A GRIN1 FAM221B SHD TRAF4 CD74	2.65e-05	185	140	6	895e8087e97ac0eab3446385e6e0dd24bea7f42c
Drug	Yohimbinic acid monohydrate [27801-27-2]; Up 200; 11.2uM; PC3; HT_HG-U133A	ATXN2L HNF1A ETV6 TFCP2L1 C11orf21 AUTS2 PLA2G6 HSF1 ARAP1 FAM149A	2.87e-07	194	137	10	4082_UP
Drug	Domperidone maleate; Down 200; 7.4uM; HL60; HT_HG-U133A	ETV6 TBX19 TOX4 C11orf21 KMT2A SMARCC2 UNKL PLA2G6 PKN1 BBC3	3.16e-07	196	137	10	1301_DN
Drug	ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA	CDC42BPA GPATCH8 TRIM33 RASGRP1 UBN1 KMT2A UNKL FOXC1 ZNF292	1.29e-06	177	137	9	985_DN
Drug	Nifuroxazide [965-52-6]; Down 200; 14.6uM; MCF7; HT_HG-U133A	DENND4A HTR1E PDK3 FNDC3A TBX19 MET COL18A1 SULF1 NBEAL2	2.42e-06	191	137	9	2850_DN
Drug	DAPH; Up 200; 10uM; PC3; HG-U133A	ATXN2L KMT2B STAT6 TRIM33 PTPN7 TRAF4 MAST4 FBXO42 SMARCC2	3.39e-06	199	137	9	578_UP
Drug	Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A	CDC42BPA SEMA5A TRIM33 MET UNKL LTBP1 ATM KIF5C	2.10e-05	191	137	8	4283_DN
Drug	Glycocholic acid [475-31-0]; Down 200; 8.6uM; MCF7; HT_HG-U133A	CDC42BPA GATA2 MLLT10 MAST4 NBEAL2 IQSEC1 KIF5C BBC3	2.35e-05	194	137	8	5316_DN
Drug	Sertaconazole nitrate [99592-39-9]; Down 200; 8uM; MCF7; HT_HG-U133A	HTR1E GATA2 FAAH MAST4 SULF1 NBEAL2 RAD54B ZNF292	2.63e-05	197	137	8	3550_DN
Drug	DAPH; Up 200; 10uM; MCF7; HG-U133A	GATA2 SEMA5A GRIN1 TRAF4 FBXO42 SMARCC2 BBC3 ZNF574	2.63e-05	197	137	8	624_UP
Drug	Phensuximide [86-34-0]; Down 200; 21.2uM; PC3; HT_HG-U133A	LZTR1 GATA2 MLLT10 TRAK1 TRIM33 MET TRAF4 RECK	2.63e-05	197	137	8	5097_DN
Drug	Vincamine [1617-90-9]; Down 200; 11.2uM; MCF7; HT_HG-U133A	HTR1E CDC42BPA TRAF4 MAST4 KMT2A LTBP1 KIF5C BBC3	2.63e-05	197	137	8	3865_DN
Drug	Pseudopelletierine hydrochloride [6164-62-1]; Up 200; 21uM; MCF7; HT_HG-U133A	CD248 ZNF362 GRIN1 ONECUT1 TBX19 UNKL PRDM16 BBC3	2.63e-05	197	137	8	2766_UP
Drug	Gramine [87-52-5]; Down 200; 23uM; MCF7; HT_HG-U133A	ATXN2L PDK3 TRAK1 MAST4 SULF1 NBEAL2 ATM ARAP1	2.72e-05	198	137	8	2799_DN
Drug	thioridazine hydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	MLLT10 ARHGEF7 SULF1 NBEAL2 IQSEC1 PKN1 LTBP1 ARAP1	2.72e-05	198	137	8	1655_DN
Drug	Epivincamine [6835-99-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A	DENND4A TRAK1 TBX19 TRIM33 MAST4 RAD54B ATM ZNF292	2.72e-05	198	137	8	6838_DN
Drug	Ajmaline [4360-12-7]; Down 200; 12.2uM; MCF7; HT_HG-U133A	MLLT10 TRAK1 STAT6 NBEAL2 KMT2A PLA2G6 HSF1 BBC3	2.72e-05	198	137	8	7484_DN
Drug	Sulindac [38194-50-2]; Down 200; 11.2uM; PC3; HT_HG-U133A	LZTR1 PDK3 TBX19 MET TRAF4 MAST4 ARAP1 ZNF574	2.82e-05	199	137	8	1815_DN
Drug	Trichlorfon [52-68-6]; Up 200; 15.6uM; PC3; HT_HG-U133A	ATXN2L HSPG2 GATA2 SEMA5A FNDC3A MLLT10 TRAK1 HSF1	2.82e-05	199	137	8	7287_UP
Drug	estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA	MET C2CD3 MAST4 SULF1 FBXO42 PKN1 ATM BBC3	2.93e-05	200	137	8	1079_DN
Drug	4-amidinophenylpyruvic acid	TPSAB1 KLK2 TPSB2	4.51e-05	12	137	3	CID000151496
Drug	Z-ARR-AFC	TPSAB1 KLK2 TPSB2	5.83e-05	13	137	3	CID000125067
Drug	Methamphetamine	ATXN2L HSPG2 FLNA FAM193B CYP2D6 MAP1A ACO2 GRIN1 MLLT10 CUBN KMT2E ONECUT1 FAAH STAT6 RASGRP1 FCGBP CNOT6L LTBP1 PRDM16 BBC3 NPAS4	9.69e-05	1401	137	21	ctd:D008694
Drug	thymidine glycol monophosphate	TPSAB1 TPSB2	1.07e-04	3	137	2	CID000165415
Drug	pyrachlostrobin	TTF2 HSPG2 FLNA TRABD2B CD248 STAT6 COL18A1 SSC5D TFCP2L1 SULF1 CNTNAP4 LTBP1 PRDM16 ARAP1 FOXC1	1.14e-04	811	137	15	ctd:C513428
Drug	Methimazole [60-56-0]; Down 200; 35uM; PC3; HT_HG-U133A	ATXN2L PDK3 TRAK1 TFCP2L1 TRIM62 ATM BBC3	1.61e-04	191	137	7	3815_DN
Drug	Remoxipride Hydrochloride [73220-03-8]; Down 200; 9.8uM; HL60; HT_HG-U133A	LZTR1 BACH1 TRAK1 IQSEC1 KMT2A PLA2G6 ZNF574	1.71e-04	193	137	7	3124_DN
Drug	indomethacin, USP; Up 200; 20uM; MCF7; HG-U133A	ATXN2L MAP1A L1CAM FNDC3A STAT6 PTPN7 ATM	1.71e-04	193	137	7	262_UP
Drug	Talampicillin hydrochloride [39878-70-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A	CDC42BPA MLLT10 TRIM33 COL18A1 MAST4 ATM KIF5C	1.71e-04	193	137	7	7014_DN
Drug	prochlorperazine dimaleate salt; Up 200; 10uM; MCF7; HG-U133A	ATXN2L GPATCH8 TRAK1 TRIM33 COL18A1 PTPN7 TRAF4	1.71e-04	193	137	7	455_UP
Drug	Halofantrine hydrochloride [36167-63-2]; Down 200; 7.4uM; MCF7; HT_HG-U133A	LZTR1 CDC42BPA FNDC3A TRIM62 FBXO42 LTBP1 FOXC1	1.77e-04	194	137	7	7469_DN
Drug	Tetrahydrozoline hydrochloride [522-48-5]; Up 200; 16.8uM; MCF7; HT_HG-U133A	LZTR1 ETV6 SEMA5A ZNF804A MAST4 ATM ARAP1	1.77e-04	194	137	7	6769_UP
Drug	Proglumide [6620-60-6]; Down 200; 12uM; MCF7; HT_HG-U133A	ATXN2L HSPG2 CDC42BPA PDK3 ETV6 ZNF804A MAST4	1.77e-04	194	137	7	3861_DN
Drug	chlorpromazine hydrochloride; Down 200; 1uM; MCF7; HT_HG-U133A	UBR2 DENND4A CDC42BPA ACO2 WASF3 TRAK1 FBXO42	1.77e-04	194	137	7	1642_DN
Drug	Midodrine hydrochloride [3092-17-9]; Down 200; 13.8uM; PC3; HT_HG-U133A	PDK3 MLLT10 IFI16 TOX4 UBN1 ATM ZNF292	1.77e-04	194	137	7	2087_DN
Drug	alpha-Santonin [481-06-1]; Down 200; 16.2uM; PC3; HT_HG-U133A	FNDC3A MET TRAF4 TFCP2L1 TOX4 TRIM62 BBC3	1.77e-04	194	137	7	3795_DN
Drug	Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A	CDC42BPA IFI16 MET UBN1 KMT2A PLA2G6 ATM	1.77e-04	194	137	7	4312_DN
Drug	clofibrate; Up 200; 150uM; MCF7; HG-U133A	ATXN2L MAP1A L1CAM FNDC3A GRIN1 PTPN7 ATM	1.77e-04	194	137	7	263_UP
Drug	Skimmianine [83-95-4]; Down 200; 15.4uM; HL60; HT_HG-U133A	DENND4A LZTR1 KMT2B MLLT10 STAT6 ARHGEF7 RECK	1.77e-04	194	137	7	2504_DN
Drug	Sisomicin sulfate [53179-09-2]; Up 200; 2.8uM; MCF7; HT_HG-U133A	QPCTL ETV6 TRAK1 FLCN KMT2A PLA2G6 ATM	1.83e-04	195	137	7	2853_UP
Drug	Lumicolchicine gamma [6901-14-0]; Down 200; 10uM; MCF7; HT_HG-U133A	HSPG2 FAAH TRAK1 MAST4 SULF1 ATM ARAP1	1.83e-04	195	137	7	3254_DN
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; PC3; HT_HG-U133A	KMT2B MAP1A SEMA5A MET COL18A1 NBEAL2 ATM	1.83e-04	195	137	7	5117_DN
Drug	Pentoxifylline [6493-05-6]; Down 200; 14.4uM; MCF7; HT_HG-U133A	TRAK1 TBX19 SULF1 C11orf21 ATM PRDM16 BBC3	1.83e-04	195	137	7	2290_DN
Drug	resveratrol; Up 200; 50uM; MCF7; HG-U133A	HNF1A LZTR1 CD248 TRAF4 FBXO42 BBC3 ARAP1	1.83e-04	195	137	7	622_UP
Drug	Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A	CDC42BPA KMT2B FNDC3A TRAK1 FLCN BBC3 FOXC1	1.89e-04	196	137	7	7226_DN
Drug	Imipramine hydrochloride [113-52-0]; Up 200; 12.6uM; HL60; HT_HG-U133A	CDC42BPA STAT6 TBX19 TRIM33 IQSEC1 KMT2A LTBP1	1.89e-04	196	137	7	1849_UP
Drug	probucol; Up 200; 10uM; MCF7; HG-U133A	HNF1A SEMA5A COL18A1 IQSEC1 LTBP1 BBC3 FOXC1	1.89e-04	196	137	7	592_UP
Drug	Canrenoic acid potassium salt [2181-04-6]; Down 200; 10uM; PC3; HT_HG-U133A	KMT2B L1CAM GATA2 IFI16 UBN1 TRIM62 KMT2A	1.89e-04	196	137	7	2065_DN
Drug	prednisolone; Down 200; 1uM; MCF7; HG-U133A	ATXN2L MAP1A L1CAM GRIN1 ONECUT1 TRIM33 ATM	1.89e-04	196	137	7	265_DN
Drug	Pergolide mesylate [66104-23-2]; Up 200; 9.8uM; PC3; HT_HG-U133A	PDK3 MLLT10 TBX19 MET ARHGEF7 UNKL KIF5C	1.89e-04	196	137	7	7271_UP
Drug	Phenelzine sulfate [156-51-4]; Down 200; 17uM; PC3; HT_HG-U133A	LZTR1 PDK3 GATA2 MLLT10 IFI16 TRAF4 RAD54B	1.89e-04	196	137	7	4538_DN
Drug	Zidovudine, AZT [30516-87-1]; Down 200; 15uM; MCF7; HT_HG-U133A	TTF2 TOX4 SULF1 IQSEC1 FLCN KIF5C BBC3	1.89e-04	196	137	7	5333_DN
Drug	Buspirone hydrochloride [33386-08-2]; Down 200; 9.4uM; MCF7; HT_HG-U133A	KMT2B STAT6 C2CD3 IQSEC1 PKN1 ATM ZNF574	1.95e-04	197	137	7	5343_DN
Drug	Panthenol (D) [81-13-0]; Down 200; 19.4uM; MCF7; HT_HG-U133A	GPATCH8 MLLT10 FAAH TRIM33 TRIM62 ATM ARAP1	1.95e-04	197	137	7	1680_DN
Drug	Skimmianine [83-95-4]; Down 200; 15.4uM; PC3; HT_HG-U133A	GATA2 SEMA5A MLLT10 TRAK1 TRIM62 FBXO42 KIF5C	1.95e-04	197	137	7	5766_DN
Drug	Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; PC3; HT_HG-U133A	LZTR1 MAP1A SEMA5A MLLT10 PLA2G6 KIF5C BBC3	1.95e-04	197	137	7	4501_DN
Drug	Flavoxate hydrochloride [3717-88-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A	CD248 GATA2 ZNF362 STAT6 TBX19 MAST4 PLA2G6	1.95e-04	197	137	7	7405_UP
Drug	Amitryptiline hydrochloride [549-18-8]; Down 200; 12.8uM; MCF7; HT_HG-U133A	LZTR1 TRAK1 MAST4 RAD54B FLCN ATM ARAP1	1.95e-04	197	137	7	5453_DN
Drug	Protoveratrine A [143-57-7]; Down 200; 5uM; MCF7; HT_HG-U133A	FLNA MET MAST4 FBXO42 IQSEC1 SMARCC2 ATM	1.95e-04	197	137	7	4963_DN
Drug	Boldine [476-70-0]; Down 200; 12.2uM; MCF7; HT_HG-U133A	LZTR1 TRIM33 COL18A1 MAST4 SULF1 NBEAL2 BBC3	1.95e-04	197	137	7	2804_DN
Drug	Cefazolin sodium salt [27164-46-1]; Down 200; 8.4uM; MCF7; HT_HG-U133A	DENND4A LZTR1 STAT6 COL18A1 MAST4 SULF1 FBXO42	2.01e-04	198	137	7	3426_DN
Drug	Pentolinium bitartrate [52-62-0]; Down 200; 7.4uM; MCF7; HT_HG-U133A	ATXN2L HSPG2 HTR1E CDC42BPA PDK3 TRIM62 RAD54B	2.01e-04	198	137	7	2305_DN
Drug	Nitrendipine [39562-70-4]; Down 200; 11uM; MCF7; HT_HG-U133A	CDC42BPA TRAK1 TBX19 TRAF4 SULF1 PLA2G6 ATM	2.01e-04	198	137	7	6464_DN
Drug	PNU-0251126 [267429-19-6]; Up 200; 1uM; PC3; HT_HG-U133A	CDC42BPA QPCTL GATA2 COL18A1 MAST4 NBEAL2 RECK	2.01e-04	198	137	7	7390_UP
Drug	Sulfamethoxazole [723-46-6]; Down 200; 15.8uM; PC3; HT_HG-U133A	HSPG2 MAP1A MLLT10 MAST4 NBEAL2 TRIM62 FLCN	2.01e-04	198	137	7	7366_DN
Drug	Hydroquinine hydrobromide hydrate [304695-81-6]; Down 200; 9.4uM; MCF7; HT_HG-U133A	HSPG2 LZTR1 HTR1E TRAK1 COL18A1 IQSEC1 BBC3	2.01e-04	198	137	7	2767_DN
Drug	quercetin dihydrate; Down 200; 1uM; MCF7; HT_HG-U133A_EA	KMT2B TRIM33 MAST4 UNKL ATM BBC3 ZNF292	2.01e-04	198	137	7	917_DN
Drug	Bromopride [4093-35-0]; Down 200; 11.6uM; MCF7; HT_HG-U133A	CDC42BPA ZNF362 FAAH TRAK1 STAT6 TBX19 PLA2G6	2.01e-04	198	137	7	6037_DN
Drug	Phenethicillin potassium salt [132-93-4]; Down 200; 10uM; MCF7; HT_HG-U133A	CDC42BPA L1CAM FNDC3A ATM KIF5C BBC3 ARAP1	2.01e-04	198	137	7	6239_DN
Drug	SC-560; Down 200; 10uM; PC3; HT_HG-U133A	HTR1E PDK3 TBX19 TRIM33 TRAF4 CTF1 FOXC1	2.01e-04	198	137	7	6865_DN
Drug	Cinoxacin [28657-80-9]; Down 200; 15.2uM; MCF7; HT_HG-U133A	PDK3 FNDC3A TOX4 MAST4 RAD54B ATM ZNF574	2.07e-04	199	137	7	3463_DN
Drug	Sulfamethoxazole [723-46-6]; Up 200; 15.8uM; PC3; HT_HG-U133A	DENND4A CDC42BPA PDK3 GATA2 MLLT10 SMARCC2 KIF5C	2.07e-04	199	137	7	7366_UP
Drug	(-)-quinpirole hydrochloride; Down 200; 1uM; MCF7; HG-U133A	ATXN2L HNF1A KMT2B PDK3 L1CAM FNDC3A FOXC1	2.07e-04	199	137	7	456_DN
Drug	Trolox [53188-07-1]; Down 200; 16uM; MCF7; HT_HG-U133A	GATA2 TBX19 MET MAST4 TRIM62 ATM ZNF292	2.07e-04	199	137	7	2883_DN
Drug	estradiol, USP; Down 200; 0.1uM; MCF7; HT_HG-U133A	CDC42BPA KMT2B TRAK1 SULF1 SMARCC2 LTBP1 ZNF574	2.07e-04	199	137	7	6968_DN
Drug	Sulmazole [73384-60-8]; Up 200; 14uM; HL60; HT_HG-U133A	HSPG2 CDC42BPA MAP1A TRAF4 KMT2A LTBP1 KIF5C	2.07e-04	199	137	7	2153_UP
Drug	Pergolide mesylate [66104-23-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A	ATXN2L LZTR1 HTR1E MLLT10 MAST4 FBXO42 ARAP1	2.13e-04	200	137	7	7031_UP
Drug	fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A	LZTR1 CDC42BPA PDK3 GATA2 FNDC3A FAAH ARHGEF7	2.13e-04	200	137	7	6996_DN
Drug	Diloxanide furoate [3736-81-0]; Down 200; 12.2uM; HL60; HT_HG-U133A	ATXN2L LZTR1 WASF3 ARHGEF7 RAD54B KMT2A PLA2G6	2.13e-04	200	137	7	3062_DN
Drug	7-methoxy-N-((6-(3-methylisothiazol-5-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-yl)methyl)-1,5-naphthyridin-4-amine	CYP2D6 MET	2.14e-04	4	137	2	ctd:C556297
Drug	Brunfelsamidine	TPSAB1 TPSB2	2.14e-04	4	137	2	CID005281683
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	HNF1A L1CAM MLLT10 ZNF804A MET FLCN ATM	6.48e-06	148	138	7	C0279702
Disease	tryptase beta-2 measurement	TPSAB1 UNKL TPSB2	8.24e-06	9	138	3	EFO_0008306
Disease	Burkitt Lymphoma	ETV6 AUTS2 KMT2A BBC3	2.40e-05	36	138	4	C0006413
Disease	Connective Tissue Diseases	TPSAB1 ZNF469 FLCN	2.77e-05	13	138	3	C0009782
Disease	Acute Myeloid Leukemia, M1	GATA2 ETV6 MLLT10 MET RASGRP1 KMT2A	2.79e-05	125	138	6	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	GATA2 ETV6 MLLT10 MET RASGRP1 KMT2A	2.79e-05	125	138	6	C1879321
Disease	Sarcomatoid Renal Cell Carcinoma	HNF1A L1CAM MLLT10 ZNF804A MET FLCN	3.19e-05	128	138	6	C1266043
Disease	Chromophobe Renal Cell Carcinoma	HNF1A L1CAM MLLT10 ZNF804A MET FLCN	3.19e-05	128	138	6	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	HNF1A L1CAM MLLT10 ZNF804A MET FLCN	3.19e-05	128	138	6	C1266044
Disease	Papillary Renal Cell Carcinoma	HNF1A L1CAM MLLT10 ZNF804A MET FLCN	3.19e-05	128	138	6	C1306837
Disease	Renal Cell Carcinoma	HNF1A L1CAM MLLT10 ZNF804A MET FLCN	3.19e-05	128	138	6	C0007134
Disease	acute myeloid leukemia (is_implicated_in)	CYP2D6 GATA2 ETV6 MLLT10 KMT2A	4.77e-05	84	138	5	DOID:9119 (is_implicated_in)
Disease	C-reactive protein measurement	UBR2 ATXN2L DCHS2 HNF1A HTR1E MAP1A CD248 ETV6 MLLT10 IFI16 ONECUT1 IFNLR1 ZNF469 SMARCC2 PLA2G6 CAMTA1 ARAP1	5.03e-05	1206	138	17	EFO_0004458
Disease	neurodegenerative disease (implicated_via_orthology)	UBR2 ACO2 GRIN1 TRAK1 PLA2G6 KIF5C	6.40e-05	145	138	6	DOID:1289 (implicated_via_orthology)
Disease	Acute myeloid leukemia	GATA2 ETV6 MLLT10	6.49e-05	17	138	3	cv:C0023467
Disease	LEUKEMIA, ACUTE MYELOID	GATA2 ETV6 MLLT10	6.49e-05	17	138	3	601626
Disease	Adenocarcinoma of large intestine	MET ZNRF3 FLCN PKN1 ATM	9.04e-05	96	138	5	C1319315
Disease	testosterone measurement	ATXN2L ZNF703 DCHS2 HNF1A DENND4A SPEM3 QPCTL MAP1A IRX1 ONECUT1 TBX19 NFIA AUTS2 MYOCD BBC3 ARAP1 FOXC1	9.92e-05	1275	138	17	EFO_0004908
Disease	Precursor B-cell lymphoblastic leukemia	ETV6 AUTS2 KMT2A	1.25e-04	21	138	3	C1292769
Disease	urate measurement, spine bone mineral density	FAM193B TOX4 PTPRD LTBP1	1.60e-04	58	138	4	EFO_0004531, EFO_0007701
Disease	Leukemia, Myelocytic, Acute	GATA2 ETV6 MLLT10 MET RASGRP1 KMT2A	1.69e-04	173	138	6	C0023467
Disease	basophil measurement	TPSAB1 ZNF469 C11orf21 TPSB2	1.82e-04	60	138	4	EFO_0803539
Disease	waist-hip ratio	QPCTL IRX1 MLLT10 ONECUT1 TRIM33 COL18A1 SSC5D DGLUCY MAST4 PTPRD UBN1 CASTOR1 ZNRF3 PRDM16 PURG FOXC1	2.05e-04	1226	138	16	EFO_0004343
Disease	unipolar depression, depressive symptom measurement	KSR2 RASGRP1 KMT2A	2.41e-04	26	138	3	EFO_0003761, EFO_0007006
Disease	myocardial infarction	HNF1A BACH1 IRX1 BCAR1 CASTOR1 MORF4L1 PRDM16 FOXC1	2.52e-04	350	138	8	EFO_0000612
Disease	body weight	ATXN2L HNF1A SH3RF1 KSR2 ETV6 MLLT10 TFCP2L1 TOX4 MAST4 ARHGEF7 CNTNAP4 AUTS2 PLA2G6 LTBP1 PURG ARAP1	2.81e-04	1261	138	16	EFO_0004338
Disease	aspartate aminotransferase measurement, serum alanine aminotransferase measurement, low density lipoprotein triglyceride measurement, body fat percentage, high density lipoprotein cholesterol measurement, sex hormone-binding globulin measurement	ATXN2L ACO2 MLLT10 ONECUT1 UBN1 AUTS2 PLA2G6 CAMTA1	3.28e-04	364	138	8	EFO_0004612, EFO_0004696, EFO_0004735, EFO_0004736, EFO_0007800, EFO_0009946
Disease	glutamate measurement	HNF1A BACH1 DGLUCY	3.35e-04	29	138	3	EFO_0010487
Disease	RENAL CELL CARCINOMA, NONPAPILLARY	HNF1A FLCN	4.49e-04	7	138	2	144700
Disease	Nonpapillary renal cell carcinoma	HNF1A FLCN	4.49e-04	7	138	2	cv:CN074294
Disease	lateral ventricle volume measurement	SEMA5A MLLT10 ZNF804B	4.93e-04	33	138	3	EFO_0008487
Disease	neuroimaging measurement	ATXN2L DCHS2 CDC42BPA KMT2B KSR2 MLLT10 COL18A1 ZNF469 MAST4 CASTOR1 ZNRF3 NFIA CAMTA1 PRDM16	5.03e-04	1069	138	14	EFO_0004346
Disease	cortical thickness	HSPG2 KMT2B TLX3 MLLT10 COL18A1 ZNF469 MAST4 UBN1 NFIA FBXO42 AUTS2 NAV1 KMT2A CAMTA1	7.45e-04	1113	138	14	EFO_0004840
Disease	ovarian carcinoma	FAM47A MLLT10 IFI16 ZNF804A ZNF804B AUTS2 PURG	8.12e-04	321	138	7	EFO_0001075
Disease	subcutaneous adipose tissue measurement	QPCTL ETV6 MLLT10 PTPRD	9.69e-04	93	138	4	EFO_0004766
Disease	eosinophilic esophagitis	SH3RF1 WASF3 BACH1 STAT6 PTPRD	1.04e-03	163	138	5	EFO_0004232
Disease	acute insulin response measurement	HNF1A ARAP1	1.16e-03	11	138	2	EFO_0006831
Disease	insomnia measurement	KSR2 MLLT10 HEXIM2 RASGRP1 PTPRD NAV1 KMT2A PURG	1.18e-03	443	138	8	EFO_0007876
Disease	lung non-small cell carcinoma (is_marker_for)	L1CAM MET IQSEC1 ATM BBC3	1.22e-03	169	138	5	DOID:3908 (is_marker_for)
Disease	fibrinogen measurement, tissue plasminogen activator measurement	ATXN2L HNF1A STXBP5	1.23e-03	45	138	3	EFO_0004623, EFO_0004791
Disease	Drugs used in diabetes use measurement	HNF1A KSR2 RASGRP1 ZNRF3 AUTS2 ARAP1	1.31e-03	255	138	6	EFO_0009924
Disease	diet measurement	TTF2 HTR1E SH3RF1 QPCTL ACO2 GPATCH8 MLLT10 ONECUT1 ZNF469 AUTS2 CAMTA1 PRDM16 PURG	1.32e-03	1049	138	13	EFO_0008111
Disease	pancreatic carcinoma	HNF1A BACH1 BCAR1 ZNRF3 PKN1	1.39e-03	174	138	5	EFO_0002618
Disease	Prenatal Exposure Delayed Effects	CYP2D6 ATM	1.39e-03	12	138	2	C0033054
Disease	Antihypertensive use measurement	HSPG2 IRX1 ZNRF3 AUTS2 PRDM16 FOXC1	1.59e-03	265	138	6	EFO_0009927
Disease	cerebral amyloid angiopathy	SH3RF1 KSR2 NFIA	1.77e-03	51	138	3	EFO_0006790
Disease	Glioblastoma Multiforme	LZTR1 TRIM33 MET RECK	1.86e-03	111	138	4	C1621958
Disease	free androgen index	HNF1A ONECUT1 TBX19 MET ZNF469 NFIA FOXC1	1.95e-03	374	138	7	EFO_0007005
Disease	monoclonal gammopathy	KSR2 PTPRD AUTS2	1.98e-03	53	138	3	EFO_0000203
Disease	neutrophil count	UBR2 HNF1A DENND4A CDC42BPA STXBP5 GATA2 ETV3 KMT2E IFI16 TBX19 TRIM33 MET NBEAL2 IQSEC1 ZNF292	2.09e-03	1382	138	15	EFO_0004833
Disease	Drug habituation	CYP2D6 ETV6 ZNF804A FAAH	2.12e-03	115	138	4	C0013170
Disease	Drug abuse	CYP2D6 ETV6 ZNF804A FAAH	2.12e-03	115	138	4	C0013146
Disease	Prescription Drug Abuse	CYP2D6 ETV6 ZNF804A FAAH	2.12e-03	115	138	4	C4316881
Disease	Substance-Related Disorders	CYP2D6 ETV6 ZNF804A FAAH	2.12e-03	115	138	4	C0236969
Disease	Drug Use Disorders	CYP2D6 ETV6 ZNF804A FAAH	2.12e-03	115	138	4	C0013222
Disease	Drug Dependence	CYP2D6 ETV6 ZNF804A FAAH	2.12e-03	115	138	4	C1510472
Disease	Substance Dependence	CYP2D6 ETV6 ZNF804A FAAH	2.12e-03	115	138	4	C0038580
Disease	Substance Use Disorders	CYP2D6 ETV6 ZNF804A FAAH	2.12e-03	115	138	4	C0038586
Disease	Organic Mental Disorders, Substance-Induced	CYP2D6 ETV6 ZNF804A FAAH	2.12e-03	115	138	4	C0029231
Disease	glucose measurement	MAPK8IP1 HNF1A QPCTL IFNLR1 AUTS2 PRDM16 ARAP1	2.13e-03	380	138	7	EFO_0004468
Disease	body fat percentage	ATXN2L ACO2 MLLT10 ONECUT1 UBN1 AUTS2 PLA2G6 CAMTA1	2.16e-03	488	138	8	EFO_0007800
Disease	Substance abuse problem	CYP2D6 ETV6 ZNF804A FAAH	2.19e-03	116	138	4	C0740858
Disease	leukemia	KMT2E KMT2A ATM	2.20e-03	55	138	3	C0023418
Disease	factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement	ATXN2L HNF1A STXBP5	2.31e-03	56	138	3	EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791
Disease	PR interval	HSPG2 ACO2 TRAK1 FREM2 ZNF469 NFIA MYOCD CAMTA1	2.35e-03	495	138	8	EFO_0004462
Disease	Cardiovascular Abnormalities	GATA2 ZNF292	2.50e-03	16	138	2	C0243050
Disease	Spondyloepiphyseal Dysplasia	HSPG2 FLNA	2.50e-03	16	138	2	C0038015
Disease	Spondyloepiphyseal Dysplasia Tarda, X-Linked	HSPG2 FLNA	2.50e-03	16	138	2	C3541456
Disease	Schwartz-Jampel Syndrome, Type 1	HSPG2 FLNA	2.50e-03	16	138	2	C4551479
Disease	Schwartz-Jampel Syndrome	HSPG2 FLNA	2.50e-03	16	138	2	C0036391
Disease	Melnick-Needles Syndrome	HSPG2 FLNA	2.50e-03	16	138	2	C0025237
Disease	Prostatic Neoplasms	WASF3 ETV3 BCAR1 MET KMT2A ATM KLK2 FOXC1 ZNF292	2.52e-03	616	138	9	C0033578
Disease	Malignant neoplasm of prostate	WASF3 ETV3 BCAR1 MET KMT2A ATM KLK2 FOXC1 ZNF292	2.52e-03	616	138	9	C0376358
Disease	colorectal cancer (is_implicated_in)	HNF1A RAD54B FLCN ATM	2.55e-03	121	138	4	DOID:9256 (is_implicated_in)
Disease	pursuit maintenance gain measurement	KSR2 COL18A1 PTPRD C11orf21	2.71e-03	123	138	4	EFO_0008433
Disease	Benign neoplasm of stomach	MET ATM	2.82e-03	17	138	2	C0153943
Disease	Neoplasm of uncertain or unknown behavior of stomach	MET ATM	2.82e-03	17	138	2	C0496905
Disease	Dystonia, Limb	KMT2B CYP2D6	2.82e-03	17	138	2	C0751093
Disease	Dystonia, Diurnal	KMT2B CYP2D6	2.82e-03	17	138	2	C0393610
Disease	Carcinoma in situ of stomach	MET ATM	2.82e-03	17	138	2	C0154060
Disease	non-Hodgkin lymphoma (is_implicated_in)	RAD54B KMT2A	2.82e-03	17	138	2	DOID:0060060 (is_implicated_in)
Disease	Van Buchem disease	HSPG2 FLNA	2.82e-03	17	138	2	C0432272
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	KMT2B ZNF292	2.82e-03	17	138	2	DOID:0060307 (is_implicated_in)
Disease	retinal vasculature measurement	LARGE2 HSPG2 CDC42BPA QPCTL ACO2 ZNF804B IQSEC1 PRDM16	3.07e-03	517	138	8	EFO_0010554
Disease	Dystonia, Paroxysmal	KMT2B CYP2D6	3.16e-03	18	138	2	C0393588
Disease	Myeloid Leukemia	KMT2E KMT2A	3.16e-03	18	138	2	C0023470
Disease	Leukemia, Monocytic, Chronic	KMT2E KMT2A	3.16e-03	18	138	2	C0023466
Disease	serum IgG glycosylation measurement	HTR1E RTCB ETV6 ZNF804A ZNF804B AUTS2 FLCN RECK	3.29e-03	523	138	8	EFO_0005193
Disease	osteochondrodysplasia (is_implicated_in)	HSPG2 FLNA	3.52e-03	19	138	2	DOID:2256 (is_implicated_in)
Disease	Osteochondrodysplasias	HSPG2 FLNA	3.52e-03	19	138	2	C0029422
Disease	Dyschondroplasias	HSPG2 FLNA	3.52e-03	19	138	2	C0013366
Disease	interstitial lung disease	HTR1E NTM-AS1 NAV1	3.85e-03	67	138	3	EFO_0004244
Disease	venous thromboembolism, fibrinogen measurement	ATXN2L DCHS2 HNF1A	3.85e-03	67	138	3	EFO_0004286, EFO_0004623
Disease	exercise test	COL18A1 PTPRD	3.90e-03	20	138	2	EFO_0004328
Disease	Multiple Epiphyseal Dysplasia	HSPG2 FLNA	3.90e-03	20	138	2	C0026760
Disease	urticaria	TPSAB1 TPSB2	3.90e-03	20	138	2	EFO_0005531
Disease	renal cell carcinoma (is_implicated_in)	HNF1A MET FLCN	4.19e-03	69	138	3	DOID:4450 (is_implicated_in)
Disease	Stomach Carcinoma	MET ATM	4.30e-03	21	138	2	C0699791
Disease	tissue plasminogen activator measurement, coronary artery disease	HNF1A STXBP5 MORF4L1	4.54e-03	71	138	3	EFO_0001645, EFO_0004791
Disease	childhood trauma measurement, alcohol consumption measurement	KSR2 PTPRD MYOCD	4.54e-03	71	138	3	EFO_0007878, EFO_0007979

Protein segments in the cluster

Peptide	Gene	Start	Entry
TPSPLVTGLHHYNPS	nan	11	Q9HAA7
HPPKDSSGQHVDVSP	ACO2	546	Q99798
VTPFPHNSSIDPHGL	BACH1	306	O14867
PHIHQTPSPSFFLQD	CAMTA1	606	Q9Y6Y1
PVVFTHLLTADHGPP	C8orf82	111	Q6P1X6
LSAPAPSHAGLPVHE	CTF1	71	Q16619
IPGVSFSPDHHTRPH	CD27	66	P26842
PSVEKGLPPSNHHAV	BCAR1	291	P56945
NGFPRTQHGPSPTVH	CASTOR1	161	Q8WTX7
AAPPLTLEGPVQSHH	BBC3	196	Q96PG8
TQTTTHLPGIPPNHA	CD248	541	Q9HCU0
HFPPLDTHSPTNDVQ	ETV3	151	P41162
PTHEGDHSVPFHRPQ	GVINP1	2301	Q7Z2Y8
ANSPFPSHPSLAHIT	RASGRP1	31	O95267
LSPPPSQCTIQHDHV	HTR1E	166	P28566
AALHPSHPDPVTVTG	CNTNAP4	1181	Q9C0A0
SVGNPTIKPHSVPSH	ARHGEF7	581	Q14155
PECQSQPAVSSPHHI	CBLL2	261	Q8N7E2
TRTFHTGQPHLVPVP	ATP5PB	31	P24539
AHVQTGITAAPPPHP	ATXN2L	966	Q8WWM7
PAFHSPHPPSEVTAS	MKRN2	76	Q9H000
SEHTVFVTPPEIPHL	DENND4A	671	Q7Z401
GPRASPHATPSTLHF	NFIA	356	Q12857
PTLATLDPPHTVHSA	RAD54B	91	Q9Y620
HHVAQEPSPGQPSTF	HSPG2	1041	P98160
HTPADTEVNLHPPTV	QPCTL	351	Q9NXS2
ESSQSVHPGVTVHPP	RECK	266	O95980
VLPEAFTIHLPHAPS	LARGE2	656	Q8N3Y3
ESPETAAHPGPIVVH	PTPN7	276	P35236
LPSVSSLPFHPQLHS	NPIPB12	466	F8W0I5
VALFPVPEGAPSVHH	MORF4L1	71	Q9UBU8
SPFFHPGNSIHTQPE	ETV6	131	P41212
PEQTNGVHTPPHVAS	FBXO42	531	Q6P3S6
FTQGLHPPLHPAASV	NTM-AS1	106	Q6ZSK4
TGQRVPVSHSFPHPL	KLK2	86	P20151
GPPSATHTPFHQSPV	MAP1A	1001	P78559
TGTPPAPRYHHSAVV	LZTR1	111	Q8N653
SPHVQIPPHVLSSEF	FLCN	421	Q8NFG4
GHTHPVATFQPSRPE	IFNLR1	271	Q8IU57
HFQGSTPASAVHRPP	FAM149A	336	A5PLN7
VPQHPPHRTASVFGT	DTX2	226	Q86UW9
SSPLKTGEQTPPHEH	MAPK8IP1	196	Q9UQF2
PLVPGSSLSPDHYEH	IQSEC1	46	Q6DN90
VQHYCHTSPTPGAPV	KSR2	206	Q6VAB6
HTSPTPGAPVYTHVD	KSR2	211	Q6VAB6
RHSGPHSPGPVTDQF	FREM2	656	Q5SZK8
TADHPVAPLGTPAHS	GPATCH8	1216	Q9UKJ3
IPGHPATFLASHPIH	GPATCH8	1426	Q9UKJ3
IIPASAIHPGPFTFH	GPATCH8	1441	Q9UKJ3
LEHVHGSGPYSAPSP	HSF1	231	Q00613
SPGISTIHLHPQFPV	LTBP1	826	Q14766
PTSPPAHSHRDFQPV	COL18A1	1566	P39060
QTPIEHVFPVPNVSH	FAM214A	191	Q32MH5
SPSQIPLEAHSPETH	FAM221B	61	A6H8Z2
GELHGVSHEPVPAPA	ONECUT1	11	Q9UBC0
FPLSLPNHSPLHSFT	AUTS2	431	Q8WXX7
PKSSTPHTPVQHGYL	KMT2E	1451	Q8IZD2
YPSQATHHTTLGPGP	KMT2E	1761	Q8IZD2
TPLHQVSPTGLEPSH	HNF1A	346	P20823
FSTPEGVPGHPEALH	L1CAM	911	P32004
PSSLTHHIPTVGDPD	KMT2B	1891	Q9UMN6
NDASPSFGLHPSPVH	MYOCD	476	Q8IZQ8
ESHNPGTNPFLIHPS	DCHS2	1551	Q6V1P9
DLPSVSSLPFHPQLH	NPIPB11	601	E5RHQ5
HEPFQTHLPTPSSTL	NPAS4	441	Q8IUM7
PPLQTTGPFARIHFH	CUBN	671	O60494
FSHSGHILPTPTPIH	GATA2	446	P23769
PHDSHTSGAPPLVNK	GSN-AS1	6	Q9NRJ2
NSTEVPPILHSNFPH	ATM	591	Q13315
PNPPHFPSHVIKATF	ATM	1376	Q13315
PHPSTFVATPASHNL	C2CD3	776	Q4AC94
PTIPGEAFPVSEHHQ	FAM193B	226	Q96PV7
TGGPFTTCHAHVPPE	FCGBP	3086	Q9Y6R7
HQVPGSPFKVPVHDV	FLNA	1431	P21333
APSAPPPHHSQGFSV	FOXC1	296	Q12948
FSVPTGQPRPSHHGV	CYP2D6	466	P10635
VVPQAPEFHPGSHTV	FNDC3A	96	Q9Y2H6
PEFHPGSHTVLHRSP	FNDC3A	101	Q9Y2H6
FLPLPPSLSHGSFHT	CARD19	176	Q96LW7
HHSPGQTPTLGQPEA	CEP170P1	236	Q96L14
PSNHTRPGPFHSKVT	ATG9B	246	Q674R7
FMTSIGPAESHPHTP	IFI16	471	Q16666
PFMTSIGPAESHPHT	IFI16	526	Q16666
HPVANPHAEISTKVP	LYAR	156	Q9NX58
VSTLPLESHHPDPNT	MAST4	2526	O15021
VSHLLPEPPETGVSH	FAM47A	196	Q5JRC9
HLHSFPAATQSSFPP	KMT2A	3161	Q03164
PHIPPVDPTTHLTFN	ELP5	241	Q8TE02
AGHTLVPFLPSNIPH	FAAH	356	O00519
EVSHIPAVHPGSFRP	CD74	216	P04233
TTGFPTHFNHEPPEE	DGLUCY	336	Q7Z3D6
DHGVPEHPTPFLAFL	PTPRD	1521	P23468
SPPVSVGSEEHPHSV	PURG	156	Q9UJV8
TEGPAHPAPHTRLFH	NAV1	1281	Q8NEY1
GPSTPHVNFLLDSHP	MET	471	P08581
GSTRAFPPHHPLIAV	RTCB	376	Q9Y3I0
HSNPGHAGPFPVVSV	TRIM33	621	Q9UPN9
HAGPFPVVSVHNTTI	TRIM33	626	Q9UPN9
HVHTVTLPPASETFP	TPSAB1	136	Q15661
HVHTVTLPPASETFP	TPSB2	136	P20231
TTHRVETPPPHQAGT	TNRC6C	771	Q9HCJ0
QHSGPFPSVPELVLH	SHD	301	Q96IW2
IRPGHYPASSPTAVH	KIF5C	926	O60282
FPDHTLSHGFPPIHQ	POU1F1	81	P28069
NPGVHPATFAAHTAP	IRX1	101	P78414
PNLDVPHGISHPGSS	HEXIM2	156	Q96MH2
VPHRQPHSFITQGSP	NBEAL2	2391	Q6ZNJ1
ADSGSSLQPLPHHPF	PRDM16	916	Q9HAZ2
VPAEQGSAAPHHPFS	PLA2G6	421	O60733
AHVVLPDPAATHDGP	PKN1	96	Q16512
SLHPQLTFTAPAPHT	SSC5D	1361	A1L4H1
PTHPVEALPVGSDHL	TFCP2L1	291	Q9NZI6
SKSHPGPVVHISDNP	STXBP5	191	Q5T5C0
PPTHTAFSGHHLPFV	CDC42BPA	386	Q5VT25
TNPVHPKHIGSIDPT	PDK3	176	Q15120
PPTSHFHVLADTPSG	SMARCC2	526	Q8TAQ2
VGLSHHSLASPQPAP	SH3RF1	621	Q7Z6J0
HDATVIHPVSPAPLN	SEMA5A	1001	Q13591
PPLHTATTNPFLTIH	MLLT10	1031	P55197
VPPPDTHGFEHTFEV	ARAP1	806	Q96P48
HGALVPPATAHEPVD	C11orf21	66	Q9P2W6
PHPHIPSDHFSLLTQ	CNOT6L	521	Q96LI5
TPVQHPETSAHHPGK	TRAK1	646	Q9UPV9
GHVAPVSPYKPGHSV	ZNF703	291	Q9H7S9
VAATPFHPSHITLQP	ZNF804B	1271	A4D1E1
HFPRDIGQPITPSHS	ZBP1	376	Q9H171
PAQAQVHSPTHTPVC	SPEM3	206	A0A1B0GUW6
TPAHIQAHTPAPTPA	SPEM3	276	A0A1B0GUW6
PHPRGSTAIFNGHTP	REV1	216	Q9UBZ9
RENGHVPFHPSSSVP	SAMD4B	196	Q5PRF9
HTPAGQAIHSPAPQS	TRABD2B	351	A6NFA1
HSHSIPPYQGLSPEE	STAT6	696	P42226
EQHFPHPIQSFSPES	PFAS	151	O15067
EHQATHFPAPVPESQ	ZNF574	231	Q6ZN55
HSLHPQPVTPSYAAG	WASF3	256	Q9UPY6
HVSPPIFPAHLASVS	ZNF292	1186	O60281
PGLAKPQHVTETFHP	TRAF4	396	Q9BUZ4
SPHNGSLFTMEPPHV	TMEM201	561	Q5SNT2
SAQTPHPHEPISFGI	TLX3	6	O43711
HLAVFAAVHPPAPSV	UNKL	361	Q9H9P5
PSAFFHPPTHPQETG	ZNF469	631	Q96JG9
QHPEHFVPSSVPEGC	UNQ6494/PRO21346	131	Q6UXR6
HAAVPTHIPQSLPGA	UBN1	1106	Q9NPG3
SLLFPTVVHVAPPSH	ZNRF3	506	Q9ULT6
SHHSPQRTESPGIPV	ZNF362	401	Q5T0B9
TPHASILSVPHTNGP	TBX19	331	O60806
SPPDIQVPGTSHFEH	UBR2	1531	Q8IWV8
HAAPHGPEDSAPQFS	SULF1	221	Q8IWU6
HPVPAALTLDPGTAH	TRIM62	291	Q9BVG3
PSHPFLSGAETFHTP	TOX4	16	O94842
GHFQERPETHSVPAP	TTF2	311	Q9UNY4
TQPPLPFKEAHVSGH	ZNF804A	1001	Q7Z570
LVSHPPTPNDHFTPT	GRIN1	91	Q05586